These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
ý
|
Definitive Proxy Statement
|
|
¨
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material under §240.14a-12
|
|
ý
|
No fee required.
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
1)
|
Amount Previously Paid:
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
3)
|
Filing Party:
|
|
4)
|
Date Filed:
|
|
ALIGN TECHNOLOGY, INC.
|
|
|
Julie Coletti
|
|
Senior Vice President, Chief Legal and Regulatory Officer
|
|
TABLE OF CONTENTS
|
Page
|
|
|
|
|
Time and Date
|
10:00 a.m., Pacific Daylight Time, on Wednesday, May 20, 2020
|
|
|
|
|
Place
|
Corporate Headquarters, 2820 Orchard Parkway, San Jose, California 95134
|
|
|
|
|
Contingent Virtual Meeting
|
Due to the ongoing and evolving public health impact of COVID-19 (coronavirus), we will continue to monitor the appropriateness of conducting the Annual Meeting in person. As a result, we may impose additional procedures or limitations on attendees beyond any described in this Notice of Annual Meeting of Stockholders and the accompanying materials in our Definitive Proxy Statement.
Alternatively, our Board may opt to change the Annual Meeting to one conducted solely by means of remote communication (i.e. a virtual-only meeting over live webcast). In the event we decide to hold our Annual Meeting remotely, we will announce the decision to do so in advance, and details on how to participate will be set forth via a press release that will be filed with the SEC and which we will make available on our website at
http://investor.aligntech.com/financial-information/sec-filings
. If you are planning to attend the Annual Meeting in person, we recommend you check with the SEC and/or our website one week in advance of May 20, 2020.
If your Notice, your proxy card or other voting instructions accompanying your proxy materials include a 11-digit or similar control number, please retain that number as you may need it to participate in the Annual Meeting if we conduct it remotely.
|
|
|
|
|
Items of Business
|
1. To elect the eleven (11) directors named in this proxy statement
2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for the fiscal year ending December 31, 2020
3. To conduct an advisory (non-binding) vote on executive compensation
4. To consider such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof
|
|
|
|
|
Adjournments and Postponements
|
Any action on the items of business described above may be considered at the annual meeting at the time and on the date specified above or at any time and date to which the annual meeting may be properly adjourned or postponed.
|
|
|
|
|
Record Date
|
Only stockholders who owned shares of our common stock at the close of business on March 25, 2020 are entitled to vote.
|
|
|
|
|
Meeting Admission
|
All stockholders as of the record date, or their duly appointed proxies, may attend the Annual Meeting. Registration will begin at 9:30 a.m. If you attend, please know that you may be asked to present valid picture identification, such as a driver’s license or passport. Stockholders holding stock in brokerage accounts (“street name” holders) will need to bring a copy of a brokerage statement reflecting stock ownership as of the record date and will be required to provide additional documentation described under
General Information - How do I vote?
and the questions and answers that follow it in the proxy statement if they intend to cast a vote at the Annual Meeting. Cameras, recording devices and other electronic devices will not be permitted at the Annual Meeting.
|
|
|
|
|
Voting
|
Your vote is very important. Regardless of whether you plan to attend the Annual Meeting, we hope you will vote as soon as possible. You may vote your shares over the Internet or by telephone. If you received a paper copy of a proxy card by mail, you may submit your proxy for the Annual Meeting by completing, signing, dating and returning your proxy card in the pre-addressed envelope provided. For specific instructions on how to vote your shares, please refer to the section entitled
General Information - How do I vote?
in the proxy statement.
|
|
Item
|
Voting Standard
|
Vote Recommendation
|
Page Reference
|
|
|
1
|
Annual Election of Directors
|
Majority of votes cast
|
FOR each nominee
|
6
|
|
2
|
Ratification of Independent Registered Public Accounting Firm
|
Majority of votes cast
|
FOR
|
20
|
|
3
|
Advisory Vote on Named Executive Officer Compensation
|
Majority of votes cast
|
FOR
|
23
|
|
|
|
|
|
Committee Memberships*
|
||||
|
Name
|
Age
|
Director Since
|
Primary Occupation
|
Independent?
|
AC
|
CC
|
NGC
|
TC
|
|
Joseph M. Hogan
|
62
|
2015
|
President & CEO, Align Technology, Inc.
|
No
|
|
|
|
|
|
Kevin J. Dallas
|
56
|
2018
|
Former Corporate Vice President, Cloud & AI Business Development, Microsoft Corporation
|
Yes
|
|
|
|
X
|
|
Joseph Lacob
|
64
|
1997
|
CEO & Governor of The Golden State Warriors
|
Yes
|
|
|
C
|
X
|
|
C. Raymond Larkin, Jr.
(1)
|
71
|
2004
|
Retired, Former Principal of Group Outcome LLC
|
Yes
|
|
|
X
|
|
|
George J. Morrow
|
68
|
2006
|
Retired, EVP of Worldwide Sales & Marketing, Amgen, Inc.
|
Yes
|
|
C
|
X
|
|
|
Anne M. Myong
|
52
|
2019
|
Chief Financial Officer of Aura Financial Corporation
|
Yes
|
X
|
|
|
|
|
Thomas M. Prescott
|
64
|
2002
|
Retired, President & CEO, Align Technology, Inc.
|
No
|
|
|
|
X
|
|
Andrea L. Saia
|
62
|
2013
|
Retired, Global Head of Vision Care, Novartis AG
|
Yes
|
X
|
X
|
|
X
|
|
Greg J. Santora
|
68
|
2003
|
Retired, CFO, Shopping.com
|
Yes
|
C
|
X
|
|
|
|
Susan E. Siegel
|
59
|
2017
|
Chief Innovation Officer at General Electric and CEO of GE Business Innovations
|
Yes
|
|
|
X
|
X
|
|
Warren S. Thaler
|
57
|
2004
|
Consultant, Gund Investment Corporation
|
Yes
|
X
|
|
X
|
X
|
|
(1)
|
Mr. Larkin is Chairman of the Board
|
|
Independence
|
|
Best Practices
|
|
9 of 11 director nominees are independent
|
|
Double trigger for all cash compensation arrangements in event of change of control for all executive officers
|
|
Independent Chairman of the Board has strong role with significant governance responsibilities
|
|
Significant stock ownership requirements for directors and executives that are reviewed annually. Our CEO is currently required to own 6x his annual base salary and our other executive officers 3x their annual base salaries. Our non-employee directors are required to own shares having a market value of $400,000
|
|
Separate CEO and Chairman of the Board roles
|
|
Independent directors meet without management present
|
|
The Audit, Compensation and Nominating and Governance Committees are each wholly comprised of independent directors
|
|
Insider Trading Policy prohibits officers, directors and employees from engaging in hedging transactions or pledging Align's securities as collateral for loans
|
|
|
|
|
|
Accountability and Diversity
|
|
Risk Oversight
|
|
Annual election of all directors
|
|
Board oversight of our overall risk management infrastructure
|
|
Majority voting in uncontested elections
|
|
Committee oversight of certain risks related to each committee's area of responsibility
|
|
Annual performance self-evaluations by the Board and committees
|
|
The Board, each of its committees and management actively promote a culture to manage risks as part of Align's corporate strategy and day-to-day operations
|
|
Believes Align benefits from having directors with a diversity of viewpoints, backgrounds, and experiences. Currently, three of our 11 directors are women
|
|
Dedicated Chief Information Security and Data Privacy Officers responsible for enterprise-wide information security strategy and data privacy policies, standards, processes, technologies and their effectiveness
|
|
•
|
Launched the Invisalign Moderate Package for the treatment of mild to moderate malocclusion that includes all the features of Invisalign treatment, plus additional features that address the orthodontic needs of teenage patients such as compliance indicators and compensation for tooth eruption
|
|
•
|
Launched the iTero Element 5D Imaging System for comprehensive, preventative and restorative oral care, expanding the suite of existing high-precision, full color imaging and fast scan times of the iTero Element portfolio
|
|
•
|
Launched the iTero Element Foundation intraoral scanner with restorative software, extending our portfolio of intraoral scanners with powerful 3D visualization to better meet the needs of doctors, labs and patients
|
|
•
|
Significantly increased our sales presence with the addition of approximately 100 new sales representatives in the first quarter of 2019 alone
|
Alignment with Stockholder Interest and Company Performance
|
•
|
Annual cash incentives are capped and subject to challenging performance goals tied to strategic annual financial goals aimed at increasing stockholder value
|
|
•
|
The majority of executive officer compensation is equity-based to align incentives with long-term stockholder value, with 100% performance-based MSUs comprising 52% of our CEO's
2019
total target compensation and, on average, 46% of the total target compensation of our other named executive officers
|
|
•
|
2019
stockholder outreach extended to holders of approximately 78% of our issued and outstanding stock and included the Chairman of our Compensation Committee, our Senior Vice President, Global Human Resources, our Vice President, Corporate Communications and Investor Relations, and a representative of our third party compensation consultant, Compensia
|
|
•
|
We appointed a new director to our Board and Audit Committee in
2019
. the third in the last three fiscal years, increasing the number of women on our Board to three
|
|
•
|
We created a Corporate Social Responsibility ("CSR") organization, appointed a full-time dedicated Senior Director of CSR, established a CSR Committee, established the pillars of our comprehensive CSR program philosophy and expanded disclosures regarding our CSR efforts
|
|
Q:
|
Why am I receiving these materials?
|
|
A:
|
Our Board of Directors (the “Board”) is providing these materials to you in connection with its solicitation of proxies for use at Align’s
2020
Annual Meeting of Stockholders, which will take place at
10:00 a.m., Pacific Time, on Wednesday, May 20, 2020
, at our corporate headquarters located at 2820 Orchard Parkway, San Jose, California 95134 (referred to in this proxy statement as the “Annual Meeting”). As a stockholder, you are invited to attend the Annual Meeting and are requested to vote on the items of business described in this proxy statement.
|
|
Q:
|
What if existing or revised COVID-19 restrictions are in effect or the Annual Meeting is held by remote communication?
|
|
A:
|
Due to the ongoing and evolving public health impact of COVID-19 (coronavirus), we are monitoring the need to impose additional procedures or limitations on attendees to protect the health and safety of our employees, directors and stockholders. Should our Board determine that any procedural or other limitations we may implement to protect the health and safety of our employees, directors or stockholders who choose to attend our Annual Meeting in person may not be effective or that to conduct the Annual Meeting in person would violate or impede any recommendations, laws or orders of public officials, we may decide to conduct the Annual Meeting solely by means of remote communication (i.e. a virtual-only meeting over live webcast). In the event we decide to modify the structure of our Annual Meeting, we will announce the decision to do so in advance, and details on how to participate will be set forth via a press release that will be filed with the SEC and available on our website at http://investor.aligntech.com/financial-information/sec-filings. If you are planning to attend the Annual Meeting in person, we recommend you check with the SEC and/or our website one week in advance of May 20, 2020.
|
|
Q:
|
What information is contained in these materials?
|
|
A:
|
The proxy materials include our proxy statement for the Annual Meeting and our
2019
Annual Report on Form 10-K ("Annual Report"). If you received a paper copy of these materials by mail, the proxy materials also include a proxy card for the Annual Meeting. If you received a notice of the Internet availability of the proxy materials instead of a paper copy of the proxy materials, see "
How do I vote?"
below. The information in this proxy statement contains important information regarding our Annual Meeting. Specifically, it identifies the proposals on which you are being asked to vote, provides information you may find useful in determining how to vote and describes the voting procedures.
|
|
Q:
|
Why did I receive a notice in the mail regarding the Internet availability of the proxy materials instead of a paper copy of the full set of proxy materials?
|
|
A:
|
In accordance with rules adopted by the SEC, we are making this proxy statement and our Annual Report available to our stockholders by providing access to such documents on the Internet instead of mailing printed copies. Stockholders will not receive printed copies of the proxy materials unless they request them. Instead, the Notice of Internet Availability of Proxy Materials ("Notice"), which was mailed to most of our stockholders, will instruct you as to how you may access and review all of the proxy materials on the Internet. The Notice also instructs you as to how you may submit your proxy via
|
|
Q:
|
Can I vote my shares by filling out and returning the Notice of Internet Availability of Proxy Materials?
|
|
A:
|
No. The Notice only identifies the items to be voted on at the Annual Meeting. You cannot vote by marking the Notice and
|
|
Q:
|
Who can vote at the Annual Meeting?
|
|
A:
|
If you are a stockholder of record or a beneficial owner who owned our common stock at the close of business on
March 25, 2020
, the record date for the Annual Meeting, you are entitled to vote at the Annual Meeting. As of the record date,
78,758,707
of our common stock were issued and outstanding and no shares of our preferred stock were issued and outstanding.
|
|
Q:
|
What is the difference between holding shares directly or as a beneficial owner, in street name?
|
|
A:
|
Most of our stockholders hold their shares as beneficial owners through a brokerage firm, bank or other nominee. As summarized below, there are some differences between shares held directly (of record) and those owned beneficially.
|
|
Q:
|
How do I vote?
|
|
A:
|
Voting via the Internet.
You may vote by proxy over the Internet by following the instructions on the Notice. Stockholders who requested to receive printed proxy materials may submit proxies over the Internet by following the instructions on the proxy card. Most of Align’s stockholders who hold shares beneficially in street name may vote by accessing the website specified in the voting instructions provided by their broker, bank or other nominee. A number of banks and brokerage firms are participating in a program provided through Broadridge Investor Communication Solutions that offers the means to grant proxies to vote shares through the Internet. If your shares are held in an account with a broker or bank participating in the Broadridge Investor Communication Solutions program, you may grant a proxy to vote those shares via the Internet by contacting the website shown on the instruction form received from your broker or bank. To be counted at the Annual Meeting, your vote via the Internet must be received by
8:59 p.m. Pacific Time, on May 19, 2020
.
|
|
Q:
|
What if I don’t give specific voting instructions?
|
|
A:
|
In the election of directors, you may vote “FOR,” “AGAINST” or “ABSTAIN.” If you elect to “ABSTAIN” in the election of directors, the abstention will not impact the election of directors. In tabulating the voting results for the election of directors, only "FOR" and "AGAINST" votes are counted.
|
|
Q:
|
Can I change or revoke my vote?
|
|
A:
|
Subject to any rules your broker or other nominee may have, you may change your proxy instructions at any time before your proxy is voted at the Annual Meeting.
|
|
•
|
grant a new proxy bearing a later date by following the instructions provided in the Notice or the proxy card, which will automatically revoke the previous proxy;
|
|
•
|
provide written notice of the revocation to:
|
|
•
|
attend the Annual Meeting and vote in person. Your attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you specifically request that it be revoked.
|
|
•
|
timely submit new voting instructions to your broker or other nominee; or
|
|
•
|
if you have obtained a legal proxy from your broker or other nominee giving you the right to vote your shares at the Annual Meeting, attend the Annual Meeting and vote in person.
|
|
Q:
|
What are we voting on and what vote is required to approve each item?
|
|
A:
|
The proposals that will be presented at the Annual meeting, our Board's voting recommendations, the vote required and the way the vote is calculated for the proposals are as follows:
|
|
PROPOSAL
|
|
Vote Required
|
|
Board's Voting Recommendation
|
|
Broker Discretionary Voting Allowed?
|
|
Proposal 1 — To Elect 11 Director Nominees
|
|
A nominee must receive more "for" votes than "against" votes and the number of votes "for" must be the majority of the required quorum
|
|
FOR
|
|
NO
|
|
|
|
|
||||
|
Proposal 2 — To Ratify the Appointment of PwC as Align’s Independent Registered Public Accounting Firm for Fiscal Year 2020
|
|
Majority of Shares Entitled to Vote and Present in Person or Represented by Proxy
|
|
FOR
|
|
YES
|
|
|
|
|
||||
|
Proposal 3 — To Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers
|
|
Majority of Shares Entitled to Vote and Present in Person or Represented by Proxy
|
|
FOR
|
|
NO
|
|
Q:
|
What constitutes a quorum?
|
|
A:
|
A quorum, which is a majority of the outstanding shares of our common stock as of the record date, must be present or represented by proxy in order to hold the Annual Meeting and to conduct business. As of the record date,
78,758,707
shares of common stock, representing the same number of votes, were outstanding. That means that we need the holders of at least
39,379,354
shares of common stock to be represented for us to have a quorum. Your shares will be counted as present at the Annual Meeting if you attend the Annual Meeting in person. Your shares will be considered present and represented by proxy if you submit a properly executed proxy card or vote via the Internet or by telephone. Under the General Corporation Law of the State of Delaware, abstentions and broker “non-votes” are counted as present and entitled to vote and so are included for purposes of determining whether a quorum is present at the Annual Meeting.
|
|
Q:
|
Who will bear the cost of soliciting votes for the Annual Meeting?
|
|
A:
|
We will bear the entire cost of proxy solicitation, including the preparation, assembly, printing and mailing of proxy materials. The original solicitation of proxies by mail may be supplemented by solicitation by telephone and other means by directors, and employees of Align. None of these officers, directors or employees will receive special compensation for such services. In addition, we may reimburse brokerage firms and other custodians for their reasonable out-of-pocket expenses for forwarding these proxy materials to you.
|
|
Q:
|
Who will count the vote?
|
|
A:
|
We expect a representative from Align will tabulate the proxies and act as inspector of the election.
|
|
Q:
|
What is Align’s website address?
|
|
A.
|
Our website address is
www.aligntech.com.
We make this proxy statement, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, available on our website in the Investors section, as soon as reasonably practicable after electronically filing such material with the Securities and Exchange Commission (“SEC”).
|
|
Q:
|
Where can I find the voting results of the meeting?
|
|
A:
|
The preliminary results will be announced at the Annual Meeting. The final results will be published in a Current Report on Form 8-K, which we will file with the SEC by
May 26, 2020
.
|
|
Q:
|
What if multiple stockholders share the same address?
|
|
A:
|
To reduce expenses, we are delivering a single copy of the Notice and, if applicable, the proxy materials to certain stockholders who share a single address, unless otherwise requested by one of the stockholders. A separate proxy card is included in the voting materials for each of these stockholders. To receive a separate copy of the Notice and, if applicable, the proxy materials you may contact us by calling (408) 470-1000 or by writing to us at Align Technology, Inc., 2820 Orchard Parkway, San Jose, California 95134, Attn: Investor Relations. You may also contact us by calling or writing if you would like to receive separate materials for future annual meetings.
|
|
Q:
|
Is there any information that I should know regarding future annual meetings?
|
|
A:
|
Stockholder proposals may be included in our proxy statement for an annual meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. For a stockholder proposal to be considered for inclusion in our proxy statement for the
2021
Annual Meeting of Stockholders, we must receive the proposal at our principal executive offices, addressed to the Corporate Secretary, no later than December 7, 2020. In addition, a stockholder proposal that is not intended for inclusion in our proxy statement under Rule 14a-8 may be brought before the 2021 Annual Meeting so long as we receive information and notice of the proposal in compliance with the requirements set forth in our Bylaws, addressed to the Corporate Secretary at our principal executive offices, not later than February 20, 2021 nor earlier than January 21, 2021.
|
|
Kevin J. Dallas
Age: 56
Director since 2018
Board committees: Technology
|
|
Kevin J. Dallas has served as a director of Align since March 2018. Mr. Dallas recently retired from Microsoft Corporation where he was most recently Corporate Vice President, Cloud & AI Business Development. At Microsoft, Mr. Dallas led a team creating partnerships that help enable the digital transformation of customers and partners across a range of industries, including connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. With advanced technologies that include intelligent cloud and intelligent edge services, Microsoft enables business outcomes that include transforming products, optimizing operations, empowering employees, and enhancing customer engagement. Prior to joining Microsoft in 1996, Mr. Dallas held roles at NVIDIA Corporation and National Semiconductor (now Texas Instruments Inc.) in the U.S., Europe and the Middle East in roles that included microprocessor design, systems engineering, product management, and end-to-end business leadership. He holds a B.S.c. degree in Electrical and Electronic Engineering from Staffordshire University, Stoke-on-Trent, Staffordshire, England.
Mr. Dallas brings to our Board an extensive strategic business background along with a deep understanding of the technology industry globally. With over 20 years' at Microsoft Corporation in senior leadership roles, Mr. Dallas understands the operational, financial and strategic issues facing worldwide technology companies today, including cybersecurity risks in enterprise operations, with significant experience in the European and Middle Eastern markets, making him well qualified for service as a director and as a member of our Technology Committee.
|
|
|
|
|
|
Joseph M. Hogan
Age: 62 Director since 2015 No Board committees |
|
Mr. Hogan has served as our President and Chief Executive Officer and a member of our Board since June 2015. Prior to joining us, Mr. Hogan was Chief Executive Officer of ABB Ltd., a global power and automation technologies company based in Zurich, Switzerland, from 2008 to 2013. Prior to ABB, Mr. Hogan worked at General Electric Company (GE) in a variety of executive and management roles from 1985 to 2008, including eight years as Chief Executive Officer of GE Healthcare from 2000 to 2008. Mr. Hogan earned a MSBA from Robert Morris University and a B.S. in Business Administration from Geneva College.
Mr. Hogan is an accomplished chief executive with extensive experience in leading the strategic and operational aspects of large and complex, international organizations in the healthcare and technology industries. As the President and Chief Executive Officer of Align, Mr. Hogan is responsible for management's execution of operational objectives and serves as an integral connection between the Board and Align's management team, enabling alignment between the Board's strategic expectations and Align's current and future strategy and operations. |
|
|
|
|
|
Joseph Lacob
Age: 64
Director since 1997
Board committees:
Nominating and Governance (Chair) and Technology |
|
Mr. Lacob has served as a director of Align since August 1997. In 2010, Mr. Lacob acquired The Golden State Warriors of the National Basketball Association. He is currently the CEO and Governor of the Warriors. From 1987 to 2018, Mr. Lacob was a partner of Kleiner Perkins Caufield & Byers (KPCB), a venture capital firm. Prior to joining KPCB in 1987, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization, and the management consulting firm of Booz, Allen & Hamilton. He previously served on the board of directors of Orexigen Therapeutics, a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Mr. Lacob received his B.S. in Biological Sciences from the University of California at Irvine, his Masters in Public Health from the University of California at Los Angeles and his M.B.A. from Stanford University.
Mr. Lacob is an accomplished business leader adept at evaluating and developing strategic opportunities. In his role at KPCB, he has gained invaluable technology, healthcare and life sciences industry experience which he shares with Align's management team and Board. During his career at KPCB, Mr. Lacob has been closely involved with investments in over fifty life science companies, including the start-up or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes over thirty therapeutic and diagnostic medical device companies. With this extensive business background, Mr. Lacob also brings considerable finance and investment experience that are invaluable to Align. |
|
|
|
|
|
C. Raymond Larkin Jr.
(Chairman of the Board) Age: 71 Director since 2004 Board committees: Nominating and Governance |
|
Mr. Larkin has served as a director of Align since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. He is currently a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Mr. Larkin was previously Chairman and Chief Executive Officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as President and Chief Executive Officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. Since January 2019, he has been the Chairman of the Board of Shockwave Medical, a publicly traded cardiovascular technology business. He previously served on the board of directors of REVA Medical Inc., a medical device company developing and commercializing bioresorbable stents for the treatment of coronary artery disease and Heartware, Inc. prior to its acquisition by Medtronic, plc in 2017. Mr. Larkin received his B.S. in Industrial Management from LaSalle University.
Mr. Larkin brings with him considerable business experience in the medical device industry serving as President and CEO of a large public company. In his decade long role as President and CEO of Nellcor Puritan Bennett, Inc., Mr. Larkin held significant management, strategic and operational responsibilities growing the company organically and acquisitively. His operational and tactical experience has proven invaluable addressing issues that have arisen at Align. With his extensive knowledge of the medical device and health care industry, Mr. Larkin provides strategic insight based on extensive prior experiences to our Board and management. Equally important to Align, Mr. Larkin’s long history serving on the boards of directors of numerous public companies has impressed upon him a deep understanding of the role and responsibilities of corporate boards that makes him the ideal person to serve as our Chairman. |
|
|
|
|
|
George J. Morrow
Age: 68 Director since 2006 Board committees: Compensation (Chair)
Nominating and Governance
|
|
Mr. Morrow has served as a director of Align since February 2006. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He is a member of the board of directors of Neurocrine Biosciences, a biotechnology company focused on neurologic, psychiatric and endocrine related disorders. He was previously on the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products from 2013 to 2019. He was on the board of Safeway Inc., a food and drug retailer from May 2013 until February 2015. From April 2015 to June 2018, he was also on the board of Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.
As a former senior executive at Amgen and Glaxo, two large public companies, Mr. Morrow brings to our Board considerable business experience in the medical technology industry. As part of the executive leadership at Amgen, Mr. Morrow had front-line exposure to many of the issues public companies continue to face, particularly on the operational, regulatory, financial and corporate governance fronts. Mr. Morrow's leadership skills and experience have given him an understanding of what makes businesses successful, which he continually shares with Align’s management team and Board. These skills and experience are extremely valuable to our Board and enable Mr. Morrow to be an effective Compensation Committee chairman and an asset to the Nominating and Governance Committee.
|
|
|
|
|
|
Anne M. Myong
Age: 52 Director since 2019 Board committees: Audit |
|
Ms. Myong was appointed to Align’s Board of Directors in August 2019. Since March 2020, Ms. Myong has served as Chief Financial Officer of Aura Financial Corporation, a Community Development Financial Institution (CDFI) and financial technology company. Previously, Ms. Myong was Senior Vice President and Chief Financial Officer at Walmart Global eCommerce, where she accelerated the growth and digital transformation of Walmart’s retail and e-commerce operations in the United States, China and Brazil. Earlier, she was Senior Vice President, Chief Financial and Administrative Officer, Walmart China Retail. In that role, she served as the senior operations and finance executive leading a retail operation of over 400 stores and 100,000 associates across China. Prior to her roles at Walmart, Ms. Myong was Vice President and CFO of Agilent Technologies China, where she was the senior finance executive of Agilent’s fastest growing and second largest market. Since 2016, she has been a board member at Goodwill Industries International. Ms. Myong holds an M.B.A. degree from Harvard Business School and a B.B.A. degree in Computer Information Systems from James Madison University.
Ms. Myong’s extensive experience in global operations, finance and digital transformation give her a unique expertise in international markets key to Align’s strategic growth. As Align continues to scale and expand, her leadership and expertise are helping to further Align’s worldwide operations while we develop and deliver industry transforming technology and innovations to doctors and their patients. As Chief Financial and Administrative Officer of Walmart China Retail, she has significant experience in our key Asian markets along with a deep understanding of financial reporting and organizational controls and monitoring needed to assist our Board, Audit Committee and executive leadership evolve as our operations expand.
|
|
|
|
|
|
Thomas M. Prescott
Age: 64 Director since 2002 Board committees: Technology |
|
Mr. Prescott served as our President and Chief Executive Officer from 2002 until his retirement in June 2015. Prior to joining Align, Mr. Prescott was President and Chief Executive Officer of Cardiac Pathways, Inc. from May 1999 to August 2001 and a consultant for Boston Scientific Corporation from August 2001 to January 2002 after its acquisition of Cardiac Pathways in August 2001. Prior to Cardiac Pathways, Mr. Prescott held various sales, general management and executive roles at Nellcor Puritan Bennett, Inc. from April 1994 to May 1999, and various management positions at GE Medical Systems from October 1987 to April 1994. In addition, Mr. Prescott served in sales, marketing and management roles at Siemens AG from December 1980 to July 1986. He received his B.S. in Civil Engineering from Arizona State University and Masters in Management from Northwestern University. Mr. Prescott has served as a member of the Board since joining Align in 2002.
Mr. Prescott's 13 years of experience as our CEO gives him a deep knowledge and understanding of Align’s business, history and evolution. When combined with his prior experience as CEO of another publicly traded medical device company, Mr. Prescott’s leadership capability and strategic and operational business acumen give him a unique perspective into Align’s business and the challenges we face. Specifically, his experience with strategic and operational issues in the life sciences industry along with his history of service on the boards of directors of other companies in this industry gives him insight into the issues facing this industry and brings valuable expertise to our Board and our Technology Committee.
|
|
|
|
|
|
Andrea L. Saia
Age: 62 Director since 2013 Board committees: Audit, Compensation and Technology |
|
Ms. Saia has served as a director of Align since July 2013. She was previously the Global Head of Vision Care in the Alcon division of Novartis AG, from 2011 until her retirement in 2012. Prior to this role, she served as President and Chief Executive Officer of CibaVision Corporation, a subsidiary of Novartis, from 2008 to 2011. From 2005 to 2007, she relocated to Switzerland and served as President of Europe, Middle East, and Africa operations, CibaVision’s largest regional business unit. She initially joined CibaVision in 2002 as Global Head of Marketing and was promoted to President of the Global Lens Business the following year. Prior to Novartis, Ms. Saia was the Chief Marketing Officer for GCG Partners Inc. Ms. Saia also held senior management and marketing positions with global consumer products companies such as Procter & Gamble Co., Unilever, and Revlon, Inc. Ms. Saia earned an M.B.A. from J.L. Kellogg Graduate School of Management and a B.S. in Business Administration from Miami University. Since July 2016, Ms. Saia has served on the board of directors of LivaNova PLC, a global medical technology company and currently serves on the board of the Farmer School of Business at Miami University. Previously, Ms. Saia served on the board of directors of Coca-Cola Enterprises, Inc., the marketer, producer and distributor of Coca-Cola products in European markets from 2012 to 2016.
Ms. Saia is an accomplished global business executive with over 30 years’ experience in the medical device and consumer products industries with multinational companies including Novartis and Unilever. The Board benefits from her far-reaching global business experience, a broad understanding of the healthcare, medical device and consumer products industries, strong management skills and operational expertise through her positions at Novartis. In those positions, she dealt with a wide range of issues as they rebuilt and strengthened the innovation and operating functions and delivered industry leading sales and profit growth. The Board believes her extensive knowledge of healthcare, medical device and consumer products industries provides her with insights that are particularly helpful and valuable to Align. In addition, Ms. Saia also serves or previously served on the board of directors of other publicly traded companies which gives her insight and perspective into current best practices at the board level and enables her to be an effective contributing member of our Board, Audit Committee, Compensation Committee and Technology Committee.
|
|
|
|
|
|
Greg J. Santora
Age: 68
Director since 2003
Board committees: Audit (Chair) and Compensation |
|
Mr. Santora has served as a director of Align since July 2003. He served as Chief Financial Officer at Shopping.com, a provider of internet-based comparison shopping resources, from December 2003 until September 2005. From 1997 through 2002, he served as Senior Vice President and Chief Financial Officer for Intuit, Inc., a provider of small business and personal finance software. Prior to Intuit, Mr. Santora spent nearly 13 years at Apple Computer in various senior financial positions including Senior Finance Director of Apple Americas and Senior Director of Internal Consulting and Audit. Mr. Santora, who began his accounting career with Arthur Andersen L.L.P., has been a CPA since 1974. He served on the board of directors of RetailMeNot, Inc., a digital coupon site, from May 2013 until its sale in May 2017. Mr. Santora holds a B.S. in Accounting from the University of Illinois and an M.B.A. from San Jose State University.
Mr. Santora is an experienced financial leader with over 35 years of finance and accounting experience gained through his education and work at a major accounting firm and his later positions as Chief Financial Officer of Intuit and Shopping.com. The compliance, financial reporting and audit expertise Mr. Santora gained in his senior finance and operations roles, including as chief financial officer, has been instrumental in addressing issues that have arisen at Align during his tenure as Audit Committee chairman. Mr. Santora's service on the board of directors and audit committee of another publicly traded company, gives him insight and perspective into current best practices with respect to finance organizations and the audit committee function.
|
|
|
|
|
|
Susan E. Siegel
Age: 59 Director since 2017
Board committees:
Nominating and Governance and Technology |
|
Ms. Siegel has been a member of our Board since 2017. In November 2017, she was appointed as Chief Innovation Officer at General Electric and Chief Executive Officer of GE Business Innovations, GE’s growth and innovation business. She was CEO of GE Ventures since 2012, which was subsumed into her new role. Prior to joining GE, from May 2006 to May 2012, she was a General Partner at Mohr Davidow Ventures, where she led healthcare and life science investments. From April 1998 to April 2006, Ms. Siegel was at Affymetrix, Inc. where she served as President and as a member of the board of directors. Since Feb 2019, Ms. Siegel has served on the board of directors of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. She also serves on the board of directors of The Engine at MIT and at The Kaiser Family Foundation. Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School.
Ms. Siegel is a purpose-driven business leader who helps companies identify and seize transformative opportunities that build markets, impact lives, and leave an enduring mark on the world. As GE’s Chief Innovation Officer and CEO of GE Ventures, Ms. Siegel led the development and acceleration of innovation across GE for seven years. Before joining GE, she was a General Partner at Mohr Davidow Ventures, where she spearheaded investments in personalized medicine, digital health and life sciences. As President and a board member of Affymetrix, she drove the company’s transformation from a pre-revenue startup to a global, multi-billion-dollar market cap leader in genomics. Based on her extensive experience pioneering and implementing industry-shifting ideas in the biomedical research and healthcare industries for more than three decades and her ability to build strong teams the Board believes Ms. Siegel is immeasurably valuable as a member of our Board, Nominating and Governance and Technology Committees. |
|
|
|
|
|
Warren S. Thaler
Age: 57 Director since 2004 Board committees: Audit, Nominating and Governance, and Technology |
|
Mr. Thaler has served as a director of Align since June 2004. Since July 2017, Mr. Thaler has been a consultant to Gund Investment Corporation, an investment firm owned by Gordon Gund with holdings in real estate and private equity securities. Prior to acting as a consultant for Gund Investment Corporation, Mr. Thaler served as its president. Since 1990, Mr. Thaler has served on the board of directors of several privately held companies owned by the Gund family. From 1990 to 2005, Mr. Thaler was on the board of directors of the Cleveland Cavaliers and Gund Arena Company and from 2001 to 2005 represented the Cleveland Cavaliers as its Alternate Governor at meetings of the National Basketball Association’s Board of Governors. Mr. Thaler received his B.A. from Princeton University and his M.B.A. from Harvard University.
Mr. Thaler’s demonstrated executive level management skills make him an important advisor to our Board. His attention to detail, success in building businesses as well as his finance and investment experience gained at Gund and through his education makes Mr. Thaler ideally suited for our Audit Committee. His business background makes him a valuable component of a well-rounded Board and a key member of the Board’s Audit, Nominating and Governance, and Technology Committees.
|
|
Position
|
|
Stock Ownership
|
|
CEO
|
|
6.0x annual base salary
|
|
Executive officers
|
|
3.0x annual base salary
|
|
Non-Employee Directors
|
|
Amount equal in market value to $400,000
|
|
•
|
shares of Align common stock held directly by the non-employee director or executive officer or in trust for the benefit of such director or officer or her or his family member living in the same household,
|
|
•
|
shares of underlying Align restricted stock units held directly by a non-employee director or executive officer, whether or not yet vested, and
|
|
•
|
50% of the gain on vested in-the-money stock options, if any.
|
|
Audit Committee
|
|
|
2019 Meetings: 10
Members: Greg J. Santora (Chair) Anne M. Myong
Andrea L. Saia
Warren S. Thaler |
Oversees and monitors our accounting and financial reporting processes, our financial statement audits, and our internal accounting and financial controls
|
|
Responsible for appointing, compensating, retaining, terminating and overseeing the work of our independent auditors
|
|
|
Responsible for reviewing the auditors proposed scope, approach and independence
|
|
|
Pre-approves audit and non-audit services
|
|
|
Provides oversight and monitors our Internal Audit Department
|
|
|
Reviews, approves and monitors our Code of Business Conduct and Ethics
|
|
|
|
Oversees and reviews our Anti-Bribery and Anti-Corruption Compliance Program
|
|
|
Oversees and reviews our cybersecurity, data privacy, and other information technology risks, controls and procedures
|
|
|
Establishes procedures for receiving, retaining and treating complaints regarding accounting, internal accounting controls or auditing matters
|
|
|
None of the Audit Committee members are employees of Align, and our Board has determined that each member is independent within the meaning of the NASDAQ listing standards and the rules and regulations of the SEC
|
|
|
Our Board has determined that Mr. Santora and Ms. Myong are each qualified as an “audit committee financial expert” within the meaning of the rules of the SEC and has confirmed that the other members of the Audit Committee are able to read and understand financial statements
|
|
Compensation Committee
|
|
|
2019 Meetings: 7
Members: George J. Morrow (Chair) Andrea L. Saia
Greg J. Santora
|
Ensures that the Align’s compensation programs successfully align the interest of employees, including executive officers, with those of the Align’s stockholders
|
|
Reviews and administers all compensation arrangements for executive officers and reviews general compensation goals and guidelines for Align’s employees and the criteria for which bonuses are to be determined
|
|
|
Retains, oversees, and assesses the independence of compensation consultants and advisors
|
|
|
|
Assists the Board in fulfilling its oversight responsibilities with respect to the management of risks arising from our compensation policies and programs
|
|
|
May form and delegate authority to subcommittees when appropriate, although no such delegation is currently in effect
|
|
|
None of the Compensation Committee members are employees of Align, and our Board has determined that each member is independent within the meaning of the NASDAQ listing standards
|
|
Nominating and Governance Committee
|
|
|
2019 Meetings: 2
Members: Joseph Lacob (Chair) C. Raymond Larkin Jr. George J. Morrow Susan E. Siegel
Warren S. Thaler
|
At the request of the Board, conducts annual reviews and makes recommendations concerning Board and executive management succession
|
|
Evaluates the composition, organization and governance of the Board and its committees
|
|
|
Develops and recommends corporate governance principles applicable to Align
|
|
|
Identifies, evaluates and recommends nominees to the Board
|
|
|
Technology Committee
|
|
|
2019 Meetings: 1
Members: Kevin J. Dallas Joseph Lacob
Thomas M. Prescott Andrea L. Saia Susan E. Siegel
Warren S. Thaler |
Reviews Align's technology and development activities Oversees and advises the Board on matters of innovation and technology
|
|
•
|
the highest personal and professional ethics and integrity;
|
|
•
|
proven achievement and competence in the nominee’s field and the ability to exercise sound business judgment;
|
|
•
|
skills and experience that are complementary to those of the existing Board;
|
|
•
|
the ability to assist and support management and make significant contributions to Align’s success; and
|
|
•
|
an understanding of the fiduciary responsibilities that is required of a member of the Board and the commitment of time and energy necessary to diligently carry out those responsibilities.
|
|
•
|
our compensation programs are designed to provide a balanced mix of cash and equity, annual, and longer-term incentives in order to encourage strategies and actions that are in the long-term best interests of Align and our stockholders;
|
|
•
|
base salaries are consistent with an employees’ responsibilities so that they are not motivated to take excessive risks to achieve a reasonable level of financial security;
|
|
•
|
we annually assess performance under prior year compensation programs and make any adjustments deemed necessary or appropriate in order to mitigate opportunities or motives for excessive risk taking;
|
|
•
|
based on the review of prior results, we annually review and establish performance goals under our annual cash incentive plan that we believe (A) are reasonable in light of past performance and market conditions, and (B) encourage success without encouraging excessive risk taking to achieve short-term results, and, therefore, do not encourage unnecessary or excessive risk-taking;
|
|
•
|
the performance goals that determine payouts under our annual cash incentive plans are company-wide in order to encourage decision-making that is in the best long-term interests of Align and our stockholders as a whole;
|
|
•
|
under our annual cash incentive plans, achievement of performance goals at levels below full target reduces only the payout related to that goal, not the other goals, and therefore does not result in an “all-or-nothing” approach;
|
|
•
|
our executive officers can receive a maximum award of 240% of their targets under our cash incentive compensation plan in order in part to avoid excessive risk taking;
|
|
•
|
the Compensation Committee has discretion over annual cash incentive program payouts;
|
|
•
|
for our executive officers, we use a portfolio of equity-based incentives that incentivize performance over a variety of time periods with respect to several balanced goals:
|
|
•
|
Restricted Stock Units ("RSUs") retain value even in a depressed market making it less likely that employees take unreasonable risks to get, or keep, equity grant “in the money”; and
|
|
•
|
Performance-based market stock units ("MSUs") measure relative stockholder return over a three-year performance cycle, thereby retaining value even if the price of Align's stock decreases in a market downturn; and
|
|
•
|
executive officers are subject to material share ownership guidelines.
|
|
Description
|
|
Current Fee
|
||
|
Annual Retainer for Board Membership (other than Chairman)
|
|
$
|
50,000
|
|
|
Annual Retainer for membership on the Compensation and/or Audit Committee (other than the Chairman)
|
|
$
|
13,500
|
|
|
Annual Retainer for Chair of Compensation Committee and/or Audit Committee
|
|
$
|
27,000
|
|
|
Annual Retainer for membership on the Nominating and Governance Committee (other than Chairman) and/or Technology Committee
|
|
$
|
5,000
|
|
|
Annual Retainer for Chair of Nominating and Governance Committee
|
|
$
|
10,000
|
|
|
Annual Retainer for Chairman of the Board
|
|
$
|
100,000
|
|
|
Name
|
|
Fees Earned or Paid in Cash ($)
|
|
Stock Awards ($)
(1)
|
|
Total ($)
|
|||
|
Kevin J. Dallas
|
|
55,000
|
|
|
299,979
|
|
|
354,979
|
|
|
Joseph Lacob
|
|
65,000
|
|
|
299,979
|
|
|
364,979
|
|
|
C. Raymond Larkin Jr.
(2)
|
|
100,000
|
|
|
399,972
|
|
|
499,972
|
|
|
George J. Morrow
|
|
82,000
|
|
|
299,979
|
|
|
381,979
|
|
|
Anne M. Myong
(3)
|
|
21,958
|
|
|
189,197
|
|
|
211,155
|
|
|
Thomas M. Prescott
|
|
55,000
|
|
|
299,979
|
|
|
354,979
|
|
|
Andrea L. Saia
|
|
82,000
|
|
|
299,979
|
|
|
381,979
|
|
|
Greg J. Santora
|
|
90,500
|
|
|
299,979
|
|
|
390,479
|
|
|
Susan E. Siegel
|
|
60,000
|
|
|
299,979
|
|
|
359,979
|
|
|
Warren S. Thaler
|
|
73,500
|
|
|
299,979
|
|
|
373,479
|
|
|
(1)
|
The amounts reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of awards of RSUs. There can be no assurance that the grant date fair value amounts will ever be realized. The RSUs are time based awards and are not subject to performance or market conditions.
|
|
(2)
|
Mr. Larkin is the Chairman of the Board.
|
|
(3)
|
Ms. Myong was appointed to the Board on August 1, 2019.
|
|
Name
|
|
Stock Awards
|
|
|
Kevin J. Dallas
|
|
921
|
|
|
Joseph Lacob
|
|
921
|
|
|
C. Raymond Larkin Jr.
(1)
|
|
1,228
|
|
|
George J. Morrow
|
|
921
|
|
|
Anne M. Myong
(2)
|
|
935
|
|
|
Thomas M. Prescott
|
|
921
|
|
|
Andrea L. Saia
|
|
921
|
|
|
Greg J. Santora
|
|
921
|
|
|
Susan E. Siegel
|
|
921
|
|
|
Warren S. Thaler
|
|
921
|
|
|
(1)
|
Mr. Larkin is the Chairman of the Board.
|
|
(2)
|
Ms. Myong was appointed to the Board on August 1, 2019.
|
|
|
2019
|
|
2018
|
||||
|
Audit fees
(1)
|
$
|
4,251,382
|
|
|
$
|
3,174,667
|
|
|
Audit-related fees
(2)
|
—
|
|
|
100,000
|
|
||
|
Tax fees
(3)
|
1,901,185
|
|
|
1,144,806
|
|
||
|
All other fees
(4)
|
8,330
|
|
|
5,040
|
|
||
|
Total fees
|
$
|
6,160,897
|
|
|
$
|
4,424,513
|
|
|
(1)
|
Audit fees
— These are fees for professional services performed by PwC for the annual audit of Align’s financial statements and review of financial statements included in Align’s quarterly filings, and services that are normally provided in connection with statutory and regulatory filings or engagements, and attest services, except those not required by statute or regulation. For 2019, these fees also include certain services performed relating to our entity reorganization wherein our Europe, Middle East, and Africa ("EMEA") regional headquarters was moved from Amsterdam, the Netherlands to Rotkreuz, Switzerland.
|
|
(2)
|
Audit-related fees
— These are fees related to assurance and related services, more specifically accounting consultations, that are also performed by PwC.
|
|
(3)
|
Tax fees
— These are fees for professional services performed by PwC with respect to tax compliance, tax advice and tax planning. For 2019, these fees also include certain services performed relating to our entity reorganization wherein our EMEA regional headquarters was moved from Amsterdam, the Netherlands to Rotkreuz, Switzerland.
|
|
(4)
|
All other fees
— These consist of all other fees billed to us for professional services performed by PwC and not reported under "Audit fees," "Audit-related fees" and "Tax fees."
|
|
•
|
the integrity of Align’s financial statements;
|
|
•
|
Align’s compliance with legal and regulatory requirements;
|
|
•
|
the independent registered public accountant’s qualifications, independence and performance;
|
|
•
|
adequacy of Align’s internal accounting and financial controls; and
|
|
•
|
Align’s internal audit department.
|
|
•
|
providing guidance with respect to Align’s relationship with the independent auditors, including having responsibility for their appointment, compensation and retention;
|
|
•
|
involved in the selection of the audit firm’s lead engagement partner;
|
|
•
|
reviewing the results and audit scope;
|
|
•
|
approving audit and non-audit services;
|
|
•
|
reviewing and discussing with management the quarterly and annual financial reports;
|
|
•
|
overseeing and reviewing Align’s enterprise risk, privacy and data security; and
|
|
•
|
overseeing management’s implementation and maintenance of effective systems of internal controls.
|
|
Respectfully submitted by:
|
|
|
AUDIT COMMITTEE
|
|
|
Greg J. Santora, Chair
|
Andrea L. Saia
|
|
Anne M. Myong
|
Warren S. Thaler
|
|
•
|
Joseph M. Hogan, our President and CEO
|
|
•
|
John F. Morici, our Chief Financial Officer and Senior Vice President, Global Finance
|
|
•
|
Julie Tay, our Senior Vice President and Managing Director, Asia Pacific
|
|
•
|
Emory M. Wright, our Senior Vice President, Global Operations
|
|
•
|
Raj Pudipeddi, our Senior Vice President and Chief Product, Innovation & Marketing Officer
|
|
•
|
Roger George, formerly our Senior Vice President, Chief Legal and Regulatory Officer
|
|
2019 Executive Compensation
|
|
The 2019 executive compensation program was designed based on Align's outstanding 2018 business and financial performance.
|
|
|
|
|
|
|
Our executive compensation program emphasizes performance-based pay:
|
|
|
|
- 91% of our CEO's total-target annual compensation was subject to annual performance goals or tied to the value of our common stock.
|
|
|
|
- 85% of our other NEO's total-target annual compensation, on average, was subject to annual performance goals or tied to the value of our common stock.
|
|
|
|
|
|
|
|
Based on strong performance against challenging 2019 financial objectives, we achieved a weighted average of 190% of our financial targets resulting in our NEOs receiving annual incentive payments (bonuses) of between 190% to 199% of their target award opportunities.
|
|
|
Strong Compensation Pay Practices
|
|
Core governance principles and practices are employed to align executive officer compensation with stockholder interests.
|
|
|
|
|
|
|
We continue to carefully manage equity burn rates with our overall equity-based burn rate for 2019 at 0.5% and our adjusted gross burn rate at 1.2%.
|
|
|
Strong 2019 Company Performance
|
|
Our stock price increased in 2019 and we outperformed the NASDAQ Composite and S&P 500 Index. Our three-year total stockholder return ("TSR") of 190% far exceeds the NASDAQ Composite Index three-year TSR of 67% and the S&P 500 Index three-year "TSR" of 44%.
|
|
|
|
|
|
|
2019 net revenues were a record $2.4 billion, a 22.4% increase from 2018.
|
|
|
|
|
|
|
|
We shipped a record 1.5 million Invisalign cases, an increase of 24.2% compared to 2018.
|
|
|
|
|
|
|
|
2019 operating income was $542.5 million, up 16.3% compared to 2018, and 22.5% of net revenues.
|
|
|
|
|
|
|
•
|
Launched
the
Invisalign Moderate Package for the treatment of mild to moderate malocclusion that includes all the features of Invisalign treatment, plus additional features that address the orthodontic needs of teenage patients such as compliance indicators and compensation for tooth eruption
|
|
•
|
Launched the iTero Element 5D Imaging System for comprehensive, preventative and restorative oral care, expanding the suite of existing high-precision, full color imaging and fast scan times of the iTero Element portfolio
|
|
•
|
Launched the iTero Element Foundation intraoral scanner with restorative software, extending our portfolio of intraoral scanners with powerful 3D visualization to better meet the needs of doctors, labs and patients
|
|
•
|
Increased the use of iTero and other digital scanners to 79.5% in the Americas and 64.7% internationally by the fourth quarter of 2019
|
|
•
|
Trained 22,270 new Invisalign doctors, 9,765 in the Americas and 12,505 internationally
|
|
•
|
Increased Invisalign total utilization rates to 15.9 cases per doctor compared to 15.7 cases in 2018
|
|
•
|
Reached our 8 million
th
Invisalign patient milestone, with international volume increasing 34.0%
|
|
•
|
Significantly increased our sales presence with the addition of approximately 100 new sales representatives in the first quarter of 2019 alone
|
|
•
|
Opened a new order acquisition and treatment facility in Wroclaw, Poland and a new treatment facility in Yokohama, Japan
|
|
•
|
We have created long-term, sustained value for our stockholders.
Our three-year TSR is 190% compared with the three-year NASDAQ Composite Index TSR and S&P 500 TSR of 67% and 44%, respectively.
|
|
•
|
Our compensation program continues to emphasize performance-based pay.
Our compensation program is designed to pay more when our financial and strategic performance is robust and less when it is not, providing built-in flexibility in the management of our operating expenses and enabling us to preserve strategic programs when economic conditions are unfavorable. A significant portion of our executive officers’ compensation is variable and tied to the success of our business and the individual performance of our executives. Consistent with this pay-for-performance orientation, Align believes that annual cash incentive (bonus) awards and long-term equity compensation should together represent the most significant portion of total target direct compensation. As a result, a larger portion of our executive officers’ total target compensation
|
|
•
|
Annual cash incentive awards reflected positive
2019
Corporate performance.
The Committee seeks to motivate executive management to continuously improve Align's financial performance through a cash incentive (bonus) plan that rewards higher performance with increased incentive opportunities. This provides us with a variable expense structure, allowing us to reduce our compensation costs in challenging times and reward performance when business conditions and results warrant. Based on our strong
2019
financial results, we achieved a weighted average of 190% of our financial targets. As a result, the annual incentive payments to our NEOs were between 190% to 199% of their target award opportunity.
|
|
•
|
Equity awards are tied to the value of our common stock.
Value received under our annual equity awards varies based on our stock price performance. In particular, payouts of our MSUs awarded to our executive officers vary based on the relative performance of our stock compared to the NASDAQ Composite Index. MSUs granted in
2019
are earned based on Align’s relative stockholder return over a three-year performance period, with 100% of the earned shares vesting at the end of three years. For MSUs granted in February 2016 that vested in February
2019
, Align stock outperformed the NASDAQ Composite Index by approximately 196% during the applicable performance period. As a result, due to Align’s continued outstanding stock price performance compared to the NASDAQ Composite Index during the performance period, the NEOs who were granted MSUs in February 2016 earned a maximum payout of 150% of their February 2016 target awards.
|
|
•
|
Compensation Committee Composed Solely of Independent Directors.
Our Compensation Committee is composed solely of independent directors and it directly retains an independent compensation consultant.
|
|
•
|
Annual Say-on-Pay Votes.
We elected to hold an annual stockholder advisory ("say-on-pay") vote, and the Compensation Committee considers the outcome of the advisory vote in making compensation decisions.
|
|
•
|
Stock Ownership Guidelines.
We maintain meaningful stock ownership guidelines for our executive officers and non-employee directors as a matter of good corporate governance and to demonstrate that the interests of our executive officers and non-employee directors are consistent with those of our stockholders. In
2019
, our stock ownership guidelines for each of our executive officers other than our CEO were 3.0x their annual salaries. Ownership guidelines for our CEO were 6.0x his annual salary. The stock ownership guidelines for our non-employee directors call for each non-employee director to own shares having $400,000 in market value.
|
|
•
|
No “single-trigger” on Cash Compensation.
All of our post-employment cash compensation arrangements in the event of a change in control of Align are “double-trigger” arrangements that require both a change in control of Align plus a qualifying termination of employment before any cash payments are paid. In addition, the employment agreements entered into by our CEO, CFO as well as any other executive officers who join us after September 2016 provide that such executive officer will
|
|
•
|
Annual Compensation-Related Risk Assessment.
Align’s executive officer compensation policies are structured to discourage inappropriate risk-taking by our executive officers. There are no guarantees that bonuses will be paid under our annual cash bonus incentive program and awards are capped at 240% of target in part to discourage excessive risk taking. The Compensation Risk Assessment located on page 16 of this proxy statement describes the Compensation Committee’s assessment that the risks arising from our company-wide compensation programs are reasonable, in the best interest of our stockholders, and unlikely to have a material adverse effect on us.
|
|
•
|
No Hedging or Pledging Company Stock.
Employees may not directly or indirectly engage in transactions intended to hedge or offset the market value of Align’s common stock owned by them. In addition, our Insider Trading Policy further prohibits employees from directly or indirectly pledging Align common stock as collateral for any obligation.
|
|
•
|
Carefully Manage Equity Burn Rates.
We are committed to carefully managing the dilutive impact of equity compensation awards. Management and the Board regularly evaluate share utilization levels by reviewing the dilutive impact of stock compensation. Align’s overall equity-award-based gross burn rate for fiscal
2019
was 0.5% and Align's adjusted gross burn rate was 1.2%. Gross burn rate is defined as the number of equity awards granted in the year divided by shares outstanding. Adjusted gross burn rate includes a premium applied to full-value shares (e.g., RSUs and MSUs) of 2.5:1. We do not reprice, buyout or exchange underwater stock options and there is no liberal counting or recycling of shares.
|
|
Year
|
“FOR” Vote
|
Year
|
“FOR” Vote
|
|
2011
|
95%
|
2016
|
92%
|
|
2012
|
92%
|
2017
|
94%
|
|
2013
|
94%
|
2018
|
95%
|
|
2014
|
93%
|
2019
|
42%
|
|
2015
|
94%
|
|
|
|
•
|
the comparison of Align’s TSR during the three-year performance period relative to the TSR of the companies in the S&P 500 Index at the beginning of the three-year performance period and which remain in the Index through the end of the three-year performance period; and
|
|
•
|
Align’s stock price at the end of the three-year performance period.
|
|
1.
|
Target pay = base salary + target bonus + accounting value of equity awards
|
|
2.
|
Indexed TSR is defined as the total stockholder return on our common stock during the period from June 1, 2015 (J. Hogan hire date) through February 20, 2019 (FY19 annual grant timing), assuming $100 was invested on June 1, 2015.
|
|
Compensation Related Matters
|
|
|
What We Heard From Stockholders
|
How We Responded
|
|
As mentioned, although most stockholders contacted understood the Compensation Committee’s rationale for the 2018 CEO MSU, it was the basis of most of our discussions and was, by itself, the driver of the majority of the negative say-on-pay vote results. Stockholders were primarily concerned with the existence, size and design of the award.
|
• The Compensation Committee believes that awarding our CEO for outstanding performance and sustained stockholder value creation is critical to our future growth.
• We included the additional disclosures above regarding the 2018 CEO MSU in an effort to increase transparency, to explain our philosophy with respect to the award and to highlight the linkage between compensation and performance.
• There were no similar one-time performance equity awards in 2019 and the Compensation Committee does not currently have plans to make similar awards in the future.
|
|
Increase proxy transparency with respect to the performance elements and goal setting of the annual compensation program.
|
We have expanded discussion of the setting and determination of performance targets for the annual compensation program, including with regard to the annual cash incentive plan and MSUs, which are entirely performance-based.
|
|
Non-Compensation Related Matters
|
|
|
What We Heard From Stockholders
|
How We Responded
|
|
Stockholders recommended we increase stockholder outreach and routinely work to build proactive relationships with stockholders throughout the year.
|
We have implemented a formal outreach program to engage with our stockholders regularly throughout the year and ask for their input on executive compensation, corporate governance and other topics of interest to stockholders.
|
|
Stockholders requested interest in additional disclosures regarding Align's ESG policies and practices.
|
• We expanded our ESG disclosures on our website and within this proxy.
• We created a Corporate Social Responsibility (“CSR”) organization, appointed a full-time dedicated Senior Director of CSR, established a CSR Committee, and established the pillars of our comprehensive CSR program philosophy.
|
|
Stockholders discussed Board governance topics including the following:
• Board Tenure & Board Succession
• CEO Succession Planning Disclosure
• Stockholder Rights and Protective Measures (proxy access, right to written consent, right to call meeting)
|
We have addressed these concerns as follows:
• We note that the Board has added three new independent Board members within the last three fiscal years, increasing the Board's diversity, and provided directors time and resources to become familiar with Align, its strategy, risks and opportunities.
• We have taken into consideration stockholders’ concerns regarding the tenures of certain of our Board members and modified discussions regarding their experiences to underscore why we believe the mix of backgrounds and skills each brings to the Board are immensely beneficial to Align and our stockholders regardless of tenure.
• The Board has engaged a third-party consultant to assist in the design of a Board succession program with the intention of implementing it in 2020.
• The Nominating and Governance Committee is enhancing our director onboarding and continuing education programs to support our existing directors and facilitate future directors.
• Each December, the Board conducts an executive succession planning summary with the assistance and input of management, where appropriate, including with regard to all Senior Vice Presidents and the CEO.
• Our Board and Nominating and Governance Committee have engaged a third-party consultant to assist in the design of a CEO Succession Program.
• Our Board and Nominating and Governance Committee reevaluated existing stockholder rights and protective measures and determined that they continue to be in the best interests of our stockholders.
|
|
•
|
Offer competitive compensation
. We seek to provide competitive compensation opportunities to attract, retain and incent superior talent.
|
|
•
|
Reward performance
. A significant portion of total target compensation for our NEOs is tied to the achievement of financial objectives. We believe that this supports our pay-for-performance philosophy by directly and substantially linking rewards to the achievement of measurable financial targets and a shared set of critical strategic priorities. By also rewarding individual performance, we seek to recognize outstanding individual contributions.
|
|
•
|
Link the interests of our executive officers with those of our stockholders
. A significant portion of total target compensation for our NEOs is tied to the achievement of financial and strategic objectives and is in the form of long-term equity-based compensation. This structure is designed to focus decision-making and behavior on goals that are consistent with Align’s overall strategy.
|
|
Responsible Party
|
|
Roles and Responsibilities
|
|
|
|
|
|
Compensation Committee
|
|
Sets Align's overall compensation philosophy, which is reviewed and approved by the Board
|
|
|
|
Reviews and approves our compensation programs; designs and monitors the execution of these programs
|
|
|
|
Reviews and approves all cash-based compensation arrangements for our executive officers (other than our CEO)
|
|
|
|
Reviews and recommends to our Board all cash-based compensation arrangements for our CEO
|
|
|
|
No member of the Compensation Committee is a former or current officer of Align or any of its subsidiaries. No executive officer of Align serves as a member of the Board or compensation committee of any entity that has one or more executive officers serving on Align's Board or Compensation Committee
|
|
|
|
|
|
Consultant to the Compensation Committee
(Compensia, Inc. an independent executive compensation consulting firm retained directly by the Compensation Committee to assist it in performing its responsibilities.)
|
|
Compensia attends meetings of the Compensation Committee and communicates outside of meetings with its members and management with respect to the design and assessment of compensation packages for our executive officers. In 2019, Compensia provided the services below on behalf of the Committee:
|
|
|
|
Analyzed whether the compensation packages of our executive officers were consistent with our compensation philosophy and competitive within the market relative to our peer companies
|
|
|
|
Assisted in defining the appropriate peer group of comparable companies
|
|
|
|
Assisted in the design of our compensation programs for executive officers and Board members, including discussing evolving compensation trends
|
|
|
|
Reviewed the effectiveness of our compensation programs
|
|
|
|
Provided advice on stock ownership guidelines for executive officers and directors
|
|
|
|
Compiled and provided market data to assist in setting our compensation philosophy, plan parameters and measures
|
|
|
|
Conducted a comprehensive review of Board compensation and provided recommendations to the Compensation Committee and the Board regarding director pay structure
|
|
|
|
Provided updates on NASDAQ listing standards, Say-on-Pay results, and regulatory developments
|
|
|
|
In addition, the Compensation Committee conducted a formal review of Compensia’s independence and is satisfied with the qualifications, performance and independence of Compensia. Compensia performed no other work for Align
|
|
|
|
|
|
Executive Officers
(Assisted by Company Staff)
|
|
Management's role is to advise the Compensation Committee regarding the alignment and weighting of our performance measures under our annual cash incentive awards with our overall strategy, the impact of the design of our equity incentive awards on our ability to attract, motivate and retain highly talented executives and the competitiveness of our compensation program. Our CEO plays a significant role in setting the compensation for other NEOs. The CEO conducts performance reviews for the other NEOs and makes recommendations to the Compensation Committee with respect to the other NEOs’ compensation. The Compensation Committee has the discretion to accept, reject, or modify the CEO's recommendations. The CEO leaves the meetings during discussions and deliberations of individual compensation actions affecting him personally. Ultimately all decisions regarding executive officer compensation are made by the Compensation Committee or in the case of CEO cash compensation, the full Board upon the recommendation of the Compensation Committee.
|
|
•
|
market comparison data (peer group data and survey data);
|
|
•
|
subjective elements, such as:
|
|
•
|
the scope of the executive officer’s role;
|
|
•
|
the executive officer’s:
|
|
•
|
experience;
|
|
•
|
qualifications;
|
|
•
|
skills; and
|
|
•
|
performance during the fiscal year (see discussion below on “
Role of Individual Performance”
);
|
|
•
|
internal equity; and
|
|
•
|
Align’s operational and financial performance.
|
|
•
|
Industry
-medical device companies and medical technology companies, which are the industries from which we primarily recruit executive talent;
|
|
•
|
Market Capitalization
-companies with a market capitalization between approximately $5.7 billion and $90.6 billion based upon the companies’ trading ranges at the time of selection which approximated 0.25 to 4.0 times Align's market capitalization at that time; and
|
|
•
|
Revenue
-companies with revenue between approximately $535.0 million to $4.8 billion based upon the last four quarters of revenue at the time of selection which approximated 0.3 to 3.0 times Align's rolling four quarters of revenues at that time.
|
|
|
|
Revenue ($B)
|
|
Market Capitalization ($B)
|
|
Market Capitalization as a Multiple of Revenue
|
|
Peer Group 50th Percentile
|
|
$2.3
|
|
$11.7
|
|
6.1x
|
|
Align
|
|
$1.6
|
|
$22.6
|
|
14.2x
|
|
Percentile Rank
|
|
28%
|
|
85%
|
|
92%
|
|
ABIOMED
|
Integra LifeSciences
|
|
Agilent Technologies*
|
Intuitive Surgical
|
|
Bio-Techne
|
Masimo
|
|
Dentsply Sirona
|
Mettler-Toledo*
|
|
DexCom
|
PerkinElmer*
|
|
Edwards Lifesciences
|
Resmed
|
|
Globus Medical
|
Teleflex*
|
|
Hologic
|
The Cooper Companies
|
|
IDEXX Labs
|
Varian Medical Systems
|
|
Illumina
|
Waters*
|
|
Element of Compensation
|
|
Target Percentile
|
|
Base salary
|
|
50
th
percentile
|
|
Target total cash compensation
|
|
65
th
to 75
th
percentile
|
|
Equity compensation
|
|
50
th
to 75
th
percentile
|
|
•
|
base salary;
|
|
•
|
annual cash incentive awards; and
|
|
•
|
long-term equity-based incentive grants.
|
|
Name
|
|
2018 Base Salary
|
|
2019 Base Salary
|
|
Percentage Increase over 2018
|
||||
|
Joseph M. Hogan
|
|
$
|
1,075,000
|
|
|
$
|
1,130,000
|
|
|
5.1%
|
|
John F. Morici
|
|
$
|
460,000
|
|
|
$
|
500,000
|
|
|
8.7%
|
|
Julie Tay
|
|
$
|
460,000
|
|
|
$
|
495,000
|
|
|
7.6%
|
|
Emory M. Wright
|
|
$
|
440,000
|
|
|
$
|
465,000
|
|
|
5.7%
|
|
Raj Pudipeddi
|
|
N/A
|
|
|
$
|
465,000
|
|
|
N/A
|
|
|
Roger George
|
|
$
|
427,000
|
|
|
$
|
440,000
|
|
|
3.0%
|
|
Measure/Weight/
Calculates
|
|
Why do we use this measure?
|
|
Target
(in millions)
|
|
Achievement
(in millions)
(1)
|
|
Level of Achievement vs Target
|
|
Impact on
Company
Multiplier
|
|
Revenues
(1) (2)
(60%)
|
|
Improvement in this measure aligns with our overall growth strategy
|
|
$2,245
|
|
$2,407
|
|
107.2%
|
|
120%
|
|
Operating income
(1) (2)
(40%)
|
|
Directly links incentive payments to company profitability and provides incentives to our employees (including our executives) to share in our profitability. Because profitability encompasses both revenue and expense management, the Compensation Committee believes this measure encourages a balanced, holistic approach by our executives to manage our business. The Compensation Committee considers operating profit before taxes because our executives cannot predict or directly affect our taxes or our tax rate.
|
|
$475
|
|
$542
|
|
114.2%
|
|
70%
|
|
COMPANY MULTIPLIER:
|
|
|
|
|
|
|
|
190%
|
||
|
(1)
|
The target performance and the level of performance at which the funding for that particular financial performance measure will be capped as follows:
|
|
•
|
A rating of zero if achievement is below 90% of target. Company performance below target automatically reduces only the payout related to that goal, not the other goals, as we want executive officers to have the same incentive to achieve other financial goals as well as their individual performance goals even if our performance tracks below the target during the course of the year;
|
|
•
|
A rating ranging from 90% to 100% if achievement meets or exceeds the minimum performance level but does not achieve the target performance level; and
|
|
•
|
A rating of 101% and above if achievement exceeds the target performance level. Each individual financial metric is uncapped; however, once the Company Multiplier reaches 240% in the aggregate, the bonus pool is fully funded. Therefore, in the aggregate, the bonus pool for our executive officers will not exceed 240% funding.
|
|
(2)
|
The Compensation Committee has the discretion to exclude the following items from Revenues and Operating Income:
|
|
(a)
|
significant and/or extraordinary items that are not indicative of our core operating performance that are separately stated on our financial statements;
|
|
(b)
|
items identified as non-GAAP in Align’s quarterly earnings announcements; and
|
|
(c)
|
other discrete items as necessary that may result in unintended gain or loss under the bonus plan.
|
|
Name
|
|
Target Incentive Award (as % of Base Salary)
|
|
Target Incentive Award
|
|
Company Multiplier
|
|
Individual Multiplier
|
|
Actual Incentive Award
|
|
Actual Award as % of Target
|
|||
|
Joseph M. Hogan
|
|
150%
|
|
$
|
1,695,000
|
|
|
190%
|
|
100%
|
|
$3,220,500
|
|
190%
|
|
|
John F. Morici
|
|
70%
|
|
350,000
|
|
|
190%
|
|
105%
|
|
698,000
|
|
|
199%
|
|
|
Julie Tay
|
|
70%
|
|
346,500
|
|
|
190%
|
|
100%
|
|
661,967
|
|
|
191%
|
|
|
Emory M. Wright
|
|
70%
|
|
325,500
|
|
|
190%
|
|
100%
|
|
618,000
|
|
|
190%
|
|
|
Raj Pudipeddi
|
|
70%
|
|
325,500
|
|
|
190%
|
|
100%
|
|
618,000
|
|
|
190%
|
|
|
Roger George
(1)
|
|
70%
|
|
308,000
|
|
|
-
|
|
-
|
|
—
|
|
|
—%
|
|
|
Award Type
|
Rationale for 2019 Portfolio
|
|
Why RSUs?
|
We believe RSUs reward retention (even in the event of a decline in Align’s share price) and provide an incentive to grow the value of Align’s stock. In addition, RSUs enable our executive officers to accumulate stock ownership in Align.
|
|
Why MSUs?
|
We believe MSUs provide a vehicle that has more consistent value delivery compared to stock options which also aligns the long-term interests of our executive officers and stockholders by rewarding executive officers for Align’s performance measured in relation to other companies over a specified period. The actual number of shares of our common stock issuable under MSUs varies based on over-or under-performance of Align’s stock price compared to the NASDAQ Composite Index during the three-year performance period. If Align under-performs the NASDAQ Composite Index, the percentage at which the MSUs convert into shares of Align stock will be reduced from 100%, at a rate of three to one (three-percentage-point reduction in units for each percentage point of under-performance), with a minimum percentage of 0%. This means that no shares will vest if Align underperforms the NASDAQ Composite by approximately 42 percentage points. If Align outperforms the NASDAQ Composite Index, the percentage at which the MSUs convert to shares will be increased from 100%, at a rate of three to one (three-percentage-point increase in units for each percentage point of over-performance), with a maximum percentage of 250%. This means that if Align outperforms the NASDAQ Composite by 42 percentage points, the maximum number of shares that will vest is 250% of the award amount. For example, if the NASDAQ Composite index increased by 10% over the performance period and our stock price increased by 30% over the performance period, then the number of shares issuable under the MSUs would be 160% of target or (130%-110%)*3=160%.
|
|
Award Type
|
Vesting Detail
|
|
RSUs
|
Typically vests over four-year with 25% vesting annually
|
|
MSUs
|
Three-year performance period with vesting at the end of year three
|
|
Name
|
|
Target Value
(RSUs)
|
|
RSU
(Shares)
|
|
Target Value
(MSUs)
(1)
|
|
Target MSUs
(1)
(Shares)
|
||||||
|
Joseph M. Hogan
|
|
$
|
3,400,000
|
|
|
13,395
|
|
|
$
|
6,799,000
|
|
|
26,789
|
|
|
John F. Morici
|
|
680,000
|
|
|
2,679
|
|
|
1,360,000
|
|
|
5,358
|
|
||
|
Julie Tay
|
|
604,000
|
|
|
2,381
|
|
|
1,209,000
|
|
|
4,763
|
|
||
|
Emory M. Wright
|
|
604,000
|
|
|
2,381
|
|
|
1,209,000
|
|
|
4,763
|
|
||
|
Raj Pudipeddi
|
|
2,352,000
|
|
|
8,930
|
|
|
—
|
|
|
—
|
|
||
|
Roger George
|
|
433,333
|
|
|
1,935
|
|
|
866,667
|
|
|
3,870
|
|
||
|
(1
)
|
The number of MSUs set forth in this column represents the Target Shares; however, the actual number of MSUs that may be earned, if any, is determined based on the formula set forth in the MSU Agreement up to a maximum of 250% of the amount of the Target Shares.
|
|
•
|
a change of control; and
|
|
•
|
termination without cause or for convenience.
|
|
THE COMPENSATION COMMITTEE
|
|
George J. Morrow, Chair
|
|
Andrea L. Saia
|
|
Greg J. Santora
|
|
Name and Principal
Position
|
|
Year
|
|
Salary
($)
|
|
Bonus ($)
(1)
|
|
Stock Awards
($)
(2)
|
|
Non-Equity
Incentive Plan
Compensation
($)
|
|
All Other
Compensation
($)
|
|
Total
($)
|
||||||
|
Joseph M. Hogan,
President and Chief Executive Officer
|
|
2019
|
|
1,125,769
|
|
|
—
|
|
|
13,901,609
|
|
|
3,220,500
|
|
|
21,261
|
|
|
18,269,139
|
|
|
|
2018
|
|
1,069,231
|
|
|
—
|
|
|
36,778,283
|
|
|
3,870,000
|
|
|
40,824
|
|
|
41,758,338
|
|
|
|
|
2017
|
|
998,077
|
|
|
—
|
|
|
7,118,945
|
|
|
3,600,000
|
|
|
27,025
|
|
|
11,744,047
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
John F. Morici,
Chief Financial Officer and
Senior Vice President, Global
Finance
|
|
2019
|
|
496,923
|
|
|
—
|
|
|
2,780,400
|
|
|
698,000
|
|
|
9,502
|
|
|
3,984,825
|
|
|
|
2018
|
|
457,539
|
|
|
—
|
|
|
2,170,410
|
|
|
718,000
|
|
|
9,234
|
|
|
3,355,183
|
|
|
|
|
2017
|
|
425,846
|
|
|
—
|
|
|
2,742,889
|
|
|
616,320
|
|
|
39,904
|
|
|
3,824,959
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Julie Tay,
Senior Vice President and
Managing Director, Asia Pacific
|
|
2019
|
|
501,891
|
|
|
—
|
|
|
2,471,513
|
|
|
661,967
|
|
|
43,172
|
|
|
3,678,543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Emory M. Wright,
Senior Vice President, Global
Operations
|
|
2019
|
|
463,077
|
|
|
—
|
|
|
2,471,513
|
|
|
618,000
|
|
|
9,425
|
|
|
3,562,015
|
|
|
|
2018
|
|
438,462
|
|
|
—
|
|
|
2,013,795
|
|
|
686,000
|
|
|
9,191
|
|
|
3,147,448
|
|
|
|
|
2017
|
|
418,077
|
|
|
—
|
|
|
1,555,085
|
|
|
604,800
|
|
|
9,632
|
|
|
2,587,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Raj Pudipeddi
Senior Vice President and Chief
Product, Innovation & Marketing
Officer
|
|
2019
|
|
402,404
|
|
|
10,000
|
|
|
2,351,716
|
|
|
618,000
|
|
|
98,648
|
|
|
3,480,768
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Roger George,
Former Senior Vice President,
Chief Legal and Regulatory
Officer
(3)
|
|
2019
|
|
303,615
|
|
|
—
|
|
|
2,518,453
|
|
|
—
|
|
|
5,407,565
|
|
|
8,229,633
|
|
|
(1)
|
Amounts reflect a one-time signing bonus for Mr. Pudipeddi.
|
|
(2)
|
The amounts shown in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. Assumptions used in the calculations of these amounts are included in Note 1 - Summary of Significant Accounting Policies, Stock-Based Compensation and Note 11 - Stockholders' Equity (collectively, "Notes 1 and 11") to our audited financial statements for the year ended
December 31, 2019
included in Align’s Annual Report on Form 10-K filed with the SEC on
February 28, 2020
. This same method was used for the years ended December 31,
2018
and
2017
.
|
|
Name
|
|
Fiscal Year 2019 RSUs
|
|
Fiscal Year 2019 MSUs
|
||||
|
Joe Hogan
|
|
$
|
3,399,517
|
|
|
$
|
10,502,092
|
|
|
John Morici
|
|
679,903
|
|
|
2,100,497
|
|
||
|
Julie Tay
|
|
604,274
|
|
|
1,867,239
|
|
||
|
Emory Wright
|
|
604,274
|
|
|
1,867,239
|
|
||
|
Raj Pudipeddi
|
|
2,351,716
|
|
|
—
|
|
||
|
Roger George
|
|
491,084
|
|
|
1,517,156
|
|
||
|
Name
|
|
Value of Fiscal Year 2019 MSUs Assuming Maximum Performance
|
||
|
Joe Hogan
|
|
$
|
16,996,951
|
|
|
John Morici
|
|
3,399,517
|
|
|
|
Julie Tay
|
|
3,022,004
|
|
|
|
Emory Wright
|
|
3,022,004
|
|
|
|
Raj Pudipeddi
|
|
—
|
|
|
|
Roger George
|
|
2,455,418
|
|
|
|
(3)
|
Mr. George's 17-year tenure with Align, most recently as our Senior Vice President, Chief Legal and Regulatory Officer, ended on May 20, 2019. He remained an employee of the Company until September 1, 2019 (the "Termination Date"). In connection with his departure, Align and Mr. George entered into a Separation and Release Agreement that provided Mr. George would receive certain benefits in accordance with his Employment Agreement, including (i) a payment of $44,483, (ii) 18 months of his base salary ($660,000), (iii) a bonus the greater of his 2019 target bonus or actual 2018 bonus ($750,000), (iv) 150% of his target bonus for fiscal year 2019 ($308,016), (v) $50,769 accrued unpaid vacation, and (vi) 18 months acceleration of vesting of his outstanding equity awards resulting in a estimated realized gain of $3,584,928. Each of the foregoing amounts is included in “All Other Compensation” in the table above and the "All Other Compensation" table below. In addition, in connection with the acceleration of Mr. George's outstanding equity awards, Align incurred a stock based compensation modification expense of $510,164, which amount has been included in the "Stock Awards" column in the table above.
|
|
Name
|
|
Dollar
Value of
Life
Insurance
Premiums
|
|
Matching
contributions
under Align’s
401(k) Plan (or retirement plan)
|
|
Relocation, Expenses
|
|
Employment Relocation Tax Neutral Compensation
|
|
Airfare for travel companion
|
|
Employee Discount Program
|
|
Severance and other Post-Employment Compensation
(1)
|
||||||||||||||
|
Mr. Hogan
|
|
$
|
1,296
|
|
|
$
|
8,400
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
11,565
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Mr. Morici
|
|
$
|
1,102
|
|
|
$
|
8,400
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Ms. Tay
|
|
$
|
—
|
|
|
$
|
12,882
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
371
|
|
|
$
|
—
|
|
|
Mr. Wright
|
|
$
|
1,025
|
|
|
$
|
8,400
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Mr. Pudipeddi
|
|
$
|
1,024
|
|
|
$
|
8,400
|
|
|
$
|
60,944
|
|
|
$
|
27,317
|
|
|
$
|
—
|
|
|
$
|
963
|
|
|
$
|
—
|
|
|
Mr. George
(1)
|
|
$
|
969
|
|
|
$
|
8,400
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,407,565
|
|
|
•
|
cash amounts that could have been received in
2019
by our NEOs under the terms of our performance-based cash incentive plan (CIP); and
|
|
•
|
time-vested RSUs and performance-based MSUs awards granted by the Compensation Committee to our NEOs in
2019
reflected on an individual grant basis.
|
|
|
|
Type
of
Award
|
|
Grant
Date
|
|
Approval
Date
|
|
Estimated
Future
Payouts
Under
Non-Equity
Incentive Plan
Awards
|
|
Non-equity Incentive
|
|
Estimated Future
Payouts Under
Equity Incentive Plan
Awards
|
|
All
Other
Stock
Awards:
Number
of
Shares
of Stock
or Units
(#)
|
|
Grant Date
Fair value
of Awards ($)
|
||||||||
|
Name
|
|
Target
($)
|
|
Maximum ($)
|
|
Target
(#)
|
|
Maximum
(#)
|
|
|||||||||||||||
|
Joseph M. Hogan
|
|
CIP
|
|
|
|
|
|
1,695,000
|
|
|
4,068,000
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
|
|
|
|
13,395
|
|
|
3,399,517
|
|
|||||
|
|
MSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
26,789
|
|
|
66,972
|
|
|
|
|
10,502,092
|
|
||||
|
John F. Morici
|
|
CIP
|
|
|
|
|
|
350,000
|
|
|
840,000
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
|
|
|
|
2,679
|
|
|
679,903
|
|
|||||
|
|
MSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
5,358
|
|
|
13,395
|
|
|
|
|
2,100,497
|
|
||||
|
Julie Tay
|
|
CIP
|
|
|
|
|
|
346,500
|
|
|
831,600
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
|
|
|
|
2,381
|
|
|
604,274
|
|
|||||
|
|
MSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
4,763
|
|
|
11,907
|
|
|
|
|
1,867,239
|
|
||||
|
Emory M. Wright
|
|
CIP
|
|
|
|
|
|
325,500
|
|
|
781,200
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
|
|
|
|
2,381
|
|
|
604,274
|
|
|||||
|
|
MSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
4,763
|
|
|
11,907
|
|
|
|
|
1,867,239
|
|
||||
|
Raj Pudipeddi
|
|
CIP
|
|
|
|
|
|
325,500
|
|
|
781,200
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
3/1/2019
|
|
2/24/2019
|
|
|
|
|
|
|
|
|
|
8,930
|
|
|
2,351,716
|
|
|||||
|
Roger George
|
|
CIP
|
|
|
|
|
|
308,000
|
|
|
739,200
|
|
|
|
|
|
|
|
|
|
||||
|
|
RSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
|
|
|
|
1,935
|
|
|
587,534
|
|
|||||
|
|
MSU
|
|
2/20/2019
|
|
1/30/2019
|
|
|
|
|
|
3,870
|
|
|
9,675
|
|
|
|
|
1,517,156
|
|
||||
|
•
|
Threshold.
There is no threshold performance level. Rather, Align's financial performance below a specific target automatically reduces only the payout related to that specific goal, not the other goals, because we want our executive officers to have the same incentive to achieve strategic priorities as well as their individual performance goals even if our financial performance tracks below the target during the course of the year.
|
|
•
|
Target.
The target amounts assume a corporate performance percentage of 100% and that the NEO received 100% of her or his target.
|
|
•
|
Maximum.
The maximum amount any executive officer can receive is capped at 240% of their target award opportunity.
|
|
•
|
Focal Awards Granted February
2019
.
The amounts shown for MSU awards granted in February
2019
represent potential share payouts with respect to MSUs. Each MSU vests over a three-year performance period, with 100% vesting as of February 2022. The actual number of MSUs eligible to vest will be determined based on a comparison of Align’s stock price performance relative to the performance of the NASDAQ Composite index over the three-year performance period, up to a maximum of 250% of the number of target shares. If Align under-performs the NASDAQ Composite index, the percentage at which the MSUs convert into shares of Align stock will be reduced from 100% at a rate of three to one (three-percentage-point reduction in units for each percentage point of under-performance), with a minimum percentage of 0%. This means that no shares will vest if Align underperforms the NASDAQ Composite index by approximately 33%. If Align outperforms the NASDAQ Composite index, the percentage at which the MSUs convert to shares will be increased from 100%, at a rate of three to one (three-percentage-point increase in units for each percentage point of over-performance), with a maximum percentage of 250%. This means that if Align outperforms the NASDAQ Composite index by approximately 33%, the maximum number of shares that will vest is 250% of the award amount.
|
|
•
|
Stock Awards.
Stock awards represent grants of RSUs under our 2005 Incentive Plan. Since RSUs are taxable to each NEO when they vest, the number of shares we issue to each NEO will be net of applicable withholding taxes which will be paid by Align on behalf of each NEO. The RSUs will result in payment to the NEO only if the vesting criteria is met and the NEO then sells the stock that has vested. Each RSU granted to our NEOs vests over a four-year period with 25% of the shares subject to vesting each anniversary of the date of grant, with full vesting in four years.
|
|
•
|
Align does not plan to time, nor has it timed, the release of material non-public information for the purpose of affecting the exercise price of its stock options should we decide to grant stock options again in the future;
|
|
•
|
Consistent with the policy described in the bullet point above, all awards of equity compensation for new employees (other than new executive officers) are made on the first day of the month for those employees who started during the period between the 16
th
day of the month that is two months prior to the grant date and the 15
th
day of the month prior to the month of the grant date. For example, May 1,
2019
grants will cover new hires starting between March 16,
2019
and April 15,
2019
; and
|
|
•
|
Annual incentive grants are made on or about the same day for all employees (including executive officers); in each of
2019
,
2018
, and
2017
such date was February 20. The Compensation Committee sets the actual grant date approximately one week following approval of the size of each grant in order to provide Align with adequate time to inform each employee individually of their grant.
|
|
Name
|
|
Stock Awards
|
||||||||||||||
|
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Market Value of Shares or Units of Stock That Have Not
Vested
($)
|
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that have Not Vested
(#)
|
|
F
o
o
t
n
o
t
e
|
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
($)
|
|||||
|
Joseph M. Hogan
|
|
7,500
|
|
|
(1)
|
|
2,092,800
|
|
|
|
|
|
|
|
||
|
|
|
12,500
|
|
|
(2)
|
|
3,488,000
|
|
|
|
|
|
|
|
||
|
|
|
7,200
|
|
|
(3)
|
|
2,009,088
|
|
|
|
|
|
|
|
||
|
|
|
13,395
|
|
|
(4)
|
|
3,737,741
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
38,000
|
|
|
(5)
|
|
10,603,520
|
|
||
|
|
|
|
|
|
|
|
|
19,200
|
|
|
(6)
|
|
5,357,568
|
|
||
|
|
|
|
|
|
|
|
|
43,100
|
|
|
(7)
|
|
12,026,624
|
|
||
|
|
|
|
|
|
|
|
|
26,789
|
|
|
(8)
|
|
7,475,203
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
John F. Morici
|
|
4,708
|
|
|
(9)
|
|
1,313,720
|
|
|
|
|
|
|
|
||
|
|
|
3,500
|
|
|
(2)
|
|
976,640
|
|
|
|
|
|
|
|
||
|
|
|
3,146
|
|
|
(10)
|
|
877,860
|
|
|
|
|
|
|
|
||
|
|
|
1,725
|
|
|
(3)
|
|
481,344
|
|
|
|
|
|
|
|
||
|
|
|
2,679
|
|
|
(4)
|
|
747,548
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
7,000
|
|
|
(5)
|
|
1,953,280
|
|
||
|
|
|
|
|
|
|
|
|
4,500
|
|
|
(6)
|
|
1,255,680
|
|
||
|
|
|
|
|
|
|
|
|
5,358
|
|
|
(8)
|
|
1,495,096
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Julie Tay
|
|
2,250
|
|
|
(1)
|
|
627,840
|
|
|
|
|
|
|
|
||
|
|
|
3,100
|
|
|
(2)
|
|
865,024
|
|
|
|
|
|
|
|
||
|
|
|
1,350
|
|
|
(3)
|
|
376,704
|
|
|
|
|
|
|
|
||
|
|
|
2,381
|
|
|
(4)
|
|
664,394
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
6,200
|
|
|
(5)
|
|
1,730,048
|
|
||
|
|
|
|
|
|
|
|
|
3,700
|
|
|
(6)
|
|
1,032,448
|
|
||
|
|
|
|
|
|
|
|
|
4,763
|
|
|
(8)
|
|
1,329,068
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Emory M. Wright
|
|
2,500
|
|
|
(1)
|
|
697,600
|
|
|
|
|
|
|
|
||
|
|
|
3,500
|
|
|
(2)
|
|
976,640
|
|
|
|
|
|
|
|
||
|
|
|
1,575
|
|
|
(3)
|
|
439,488
|
|
|
|
|
|
|
|
||
|
|
|
2,381
|
|
|
(4)
|
|
664,394
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
7,000
|
|
|
(5)
|
|
1,953,280
|
|
||
|
|
|
|
|
|
|
|
|
4,200
|
|
|
(6)
|
|
1,171,968
|
|
||
|
|
|
|
|
|
|
|
|
4,763
|
|
|
(8)
|
|
1,329,068
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Raj Pudipeddi
|
|
8,930
|
|
|
(11)
|
|
2,491,827
|
|
|
|
|
|
|
|
||
|
(1)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on February 20, 2017, February 20, 2018, February 20, 2019 and February 20, 2020.
|
|
(2)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on February 20, 2018, February 20, 2019, February 20, 2020, and February 20, 2021.
|
|
(3)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on February 20, 2019, February 20, 2020, February 20, 2021, and February 20, 2022.
|
|
(4)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on February 20, 2020, February 20, 2021, February 20, 2022, and February 20, 2023.
|
|
(5)
|
MSUs vest 100% on February 20, 2020.
|
|
(6)
|
MSUs vest 100% on February 20, 2021.
|
|
(7)
|
MSUs vest 100% on June 2021.
|
|
(8)
|
MSUs vest 100% on February 20, 2022.
|
|
(9)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on November 20, 2017, November 20, 2018, November 20, 2019, and November 20, 2020.
|
|
(10)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on September 20, 2018, September 20, 2019, September 20, 2020, and September 20, 2021.
|
|
(11)
|
RSUs vest at a rate of 25% of the total number of shares on the first year, second year, third year and fourth year anniversary of the date of grant for vesting on March 20, 2020, March 20, 2021, March 20, 2022 and March 20, 2023
|
|
|
|
Stock Awards
|
|||||
|
Name
|
|
Number of
Shares
Acquired
on Vesting
(1)
|
|
Value
Realized
on
Vesting
(2)
|
|||
|
Joseph M. Hogan
|
|
85,150
|
|
|
$
|
21,610,219
|
|
|
John F. Morici
|
|
8,607
|
|
|
$
|
2,149,127
|
|
|
Julie Tay
|
|
19,230
|
|
|
$
|
4,880,382
|
|
|
Emory M. Wright
|
|
21,900
|
|
|
$
|
5,558,001
|
|
|
Raj Pudipeddi
|
|
—
|
|
|
$
|
—
|
|
|
Roger George
|
|
40,953
|
|
|
$
|
9,009,689
|
|
|
(1)
|
For each NEO, such number of shares represents the gross number of shares acquired by the NEO on the vesting date; however, because RSUs and MSUs are taxable to the individuals when they vest, the number of shares we issue to each of our NEOs is net of applicable withholding taxes which are paid by us on their behalf.
|
|
(2)
|
The value realized on vesting equals the closing price per share of our common stock as reported on the NASDAQ Global Market on the vesting date multiplied by the gross number of shares acquired on vesting as described above in note 1.
|
|
Name
|
|
Type of Payment
|
|
Payments Upon
Involuntary or Good
Reason Termination
Unrelated to
Change of Control
|
|
Payments Upon
Involuntary or
Good Reason
Termination
Related to a
Change of
Control
|
|
Change of
Control
Only
|
|
Death or Disability
|
||||||||
|
Joseph M. Hogan
|
|
Severance Payment
|
|
$
|
7,825,000
|
|
|
$
|
7,825,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
RSUs
|
|
$
|
—
|
|
|
$
|
11,327,629
|
|
|
$
|
5,440,931
|
|
|
$
|
11,327,629
|
|
|
|
|
MSUs
|
|
$
|
—
|
|
|
$
|
89,368,838
|
|
|
$
|
52,318,277
|
|
|
$
|
89,368,838
|
|
|
|
|
Health and Welfare Benefits
|
|
$
|
1,485
|
|
|
$
|
1,485
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
Total
|
|
$
|
7,826,485
|
|
|
$
|
108,522,952
|
|
|
$
|
57,759,208
|
|
|
$
|
100,696,467
|
|
|
(1)
|
twice his then current annual base salary;
|
|
(2)
|
the then current year’s target bonus, prorated for the number of days Mr. Hogan has been employed during the year; and
|
|
(3)
|
the greater of 150% of the then current year’s target bonus or the prior year’s actual bonus.
|
|
•
|
the performance period shall be deemed to end upon the closing of the change of control in order to determine Align’s stock price performance relative to the NASDAQ Composite index for the purpose of calculating the amount that Align has over or underperformed the NASDAQ Composite index (with the MSUs converting into shares of Align stock either being reduced from 100% (in the case of underperformance) or increased from 100% (in the case of overperformance) (the “Performance Multiplier”); and
|
|
•
|
Align’s stock price performance will be based on the per share value of Align’s common stock paid to its stockholders in connection with the change of control.
|
|
(1)
|
twice his then current annual salary;
|
|
(2)
|
the then current year’s target bonus, prorated for the number of days Mr. Hogan has been employed during the year; and
|
|
(3)
|
the greater of 150% of the then current year’s target bonus or the prior year’s actual bonus.
|
|
Name
|
|
Type of Payment
|
|
Payments Upon
Involuntary or
Good
Reason Termination
Unrelated to
Change
of Control
|
|
Payments Upon
Involuntary or
Good Reason
Termination
Related to a
Change of
Control
|
|
Change of
Control Only
|
||||
|
John F. Morici
|
|
Severance Payment
|
|
$
|
500,000
|
|
|
$
|
1,568,000
|
|
|
N/A
|
|
|
|
RSUs
|
|
$
|
—
|
|
|
$
|
4,397,043
|
|
|
N/A
|
|
|
|
MSUs
|
|
$
|
—
|
|
|
$
|
10,783,501
|
|
|
|
|
|
|
Health and Welfare Benefits
|
|
$
|
—
|
|
|
$
|
28,493
|
|
|
N/A
|
|
|
|
Total
|
|
$
|
500,000
|
|
|
$
|
16,777,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Raj Pudipeddi
|
|
Severance Payment
|
|
$
|
465,000
|
|
|
$
|
1,116,000
|
|
|
N/A
|
|
|
|
RSUs
|
|
|
|
$
|
2,491,827
|
|
|
N/A
|
||
|
|
|
MSUs
|
|
|
|
$
|
—
|
|
|
|
||
|
|
|
Health and Welfare Benefits
|
|
|
|
$
|
28,493
|
|
|
N/A
|
||
|
|
|
Total
|
|
$
|
465,000
|
|
|
$
|
3,636,320
|
|
|
|
|
(i)
|
his then current annual base salary;
|
|
(ii)
|
his then current year’s target bonus, prorated for the number of days he has been employed during the year; and
|
|
(iii)
|
the greater of his then current year’s target bonus or the prior year’s actual bonus.
|
|
|
||||||||||||||
|
Name
|
|
Type of Payment
|
|
Payments Upon
Involuntary or Good
Reason Termination
Unrelated to Change
of Control
|
|
Payments Upon
Involuntary or
Good Reason
Termination
Related to a
Change of
Control
|
|
Change of
Control Only
|
||||||
|
Julie Tay
|
|
Severance Payment
|
|
$
|
1,565,500
|
|
|
$
|
1,565,500
|
|
|
$
|
—
|
|
|
|
|
RSUs
|
|
$
|
1,352,019
|
|
|
$
|
2,533,962
|
|
|
$
|
1,352,019
|
|
|
|
|
MSUs
|
|
$
|
5,860,824
|
|
|
$
|
9,363,885
|
|
|
$
|
5,860,824
|
|
|
|
|
Health and Welfare Benefits
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
|
|
|
Total
|
|
$
|
8,778,343
|
|
|
$
|
13,463,347
|
|
|
$
|
7,212,843
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Emory M. Wright
|
|
Severance Payment
|
|
$
|
1,476,500
|
|
|
$
|
1,476,500
|
|
|
$
|
—
|
|
|
|
|
RSUs
|
|
$
|
1,498,515
|
|
|
$
|
2,778,122
|
|
|
$
|
1,498,515
|
|
|
|
|
MSUs
|
|
$
|
6,503,508
|
|
|
$
|
10,159,149
|
|
|
$
|
6,503,508
|
|
|
|
|
Health and Welfare Benefits
|
|
$
|
28,493
|
|
|
$
|
28,493
|
|
|
$
|
26,888
|
|
|
|
|
Total
|
|
$
|
9,507,016
|
|
|
$
|
14,442,264
|
|
|
$
|
8,028,911
|
|
|
(i)
|
if Align under-performs the NASDAQ Composite index, the percentage at which the MSUs convert into shares of Align stock will be reduced from 100% at a rate of three to one; and
|
|
(ii)
|
if Align outperforms the index, the percentage at which the MSUs convert to shares will be increased from 100% at a rate of three to one.
|
|
(3)
|
she or he is also entitled to receive a lump sum payment equal to:
|
|
(i)
|
her or his then current annual base salary;
|
|
(ii)
|
her or his then current year’s target bonus, prorated for the number of days she or he has been employed during the year; and
|
|
(iii)
|
the greater of her or his then current year’s target bonus or the prior year’s actual bonus.
|
|
•
|
the performance period shall be deemed to end upon the closing of the change of control in order to determine Align’s stock price performance relative to the NASDAQ Composite index for the purpose of calculating the amount that Align has over or underperformed the NASDAQ Composite index (with the MSUs converting into shares of Align stock either being reduced from 100% (in the case of underperformance) or increased from 100% (in the case of overperformance) at a rate of two to one (for 2016 grants) or at a rate of three to one (for grants made in 2017 and 2018) (the “Performance Multiplier”); and
|
|
•
|
Align’s stock price performance will be based on the per share value of the Company’s common stock paid to its stockholders in connection with the change of control.
|
|
(i)
|
her or his then current annual base salary;
|
|
(ii)
|
her or his then current year’s target bonus prorated for the number of days employed during the year, and
|
|
(iii)
|
the greater of her or his then current year’s target bonus or the prior year’s actual bonus.
|
|
•
|
unauthorized use or disclosure of the confidential information or trade secrets of Align;
|
|
•
|
any breach of the employment agreement or the Employee Proprietary Information and Inventions Agreement between the executive officer and Align;
|
|
•
|
conviction of, or a plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof;
|
|
•
|
misappropriation of the assets of Align or any act of fraud or embezzlement by the executive officer, or any act of dishonesty by the executive officer in connection with the performance of her or his duties for Align that adversely affects its business or affairs;
|
|
•
|
intentional misconduct; or
|
|
•
|
the executive officer’s failure to satisfactorily perform her or his duties after the executive officer has received written notice of such failure and was provided at least thirty (30) days to cure such failure.
|
|
•
|
the executive officer’s position, authority or responsibilities being significantly reduced;
|
|
•
|
the executive officer being asked to relocate her or his principal place of employment such that the commuting distance from her or his residence prior to the change of control is increased by over thirty-five (35) miles;
|
|
•
|
the executive officer’s annual base salary or bonus being reduced; or
|
|
•
|
the executive officer’s benefits being materially reduced.
|
|
•
|
a sale of all or substantially all of Align’s assets;
|
|
•
|
the acquisition of more than 50% of the common stock of Align by any person or group of persons;
|
|
•
|
a reorganization of Align wherein the holders of common stock of Align receive stock in another company (other than a subsidiary of Align), a merger of Align with another company wherein there is a 50% or greater change in the ownership of the common stock of Align as a result of such merger, or any other transaction in which Align (other than as the parent corporation) is consolidated for federal income tax purposes or is eligible to be consolidated for federal income tax purposes with another corporation; or
|
|
•
|
in the event that the common stock is traded on an established securities market, a public announcement that any person has acquired or has the right to acquire beneficial ownership of more than 50% of the then outstanding common stock of Align, or the commencement of or public announcement of an intention to make a tender offer or exchange offer for more than 50% of Align's then outstanding common stock.
|
|
•
|
The Align Foundation -
Recently launched in 2020, the Align Foundation provides a structured way to direct significant donations from a charitable investment fund, the flexibility to provide smaller monetary donations, processes to donate our products (the Invisalign System and iTero scanners) and organized ways to involve our employees in giving activities.
|
|
•
|
Operation Smile - Since 2013, we have supported Operation Smile, an international medical charity that provides free surgeries to children and young adults in developing countries born with cleft lip, cleft palate or other dental and facial conditions. Consistent with our mission to transform smiles and change lives, it is a partnership that continues to grow and evolve. To date, we have donated approximately $1.4 million, enabling the organization to deliver the highest quality surgical care to tens of thousands of the world’s most vulnerable patients, and grow its reach to more than 60 countries. We were a corporate sponsor of Operation Smile’s 2018 International Student Leadership Conference and have committed to sponsor the event again in 2020. In recognition of our support of its mission, in November 2018 Align received Operation Smile's Corporate Humanitarian Award.
|
|
•
|
Month of Smiles - Since 2018, we established a dedicated month of giving which we call the Month of Smiles, where all employees are encouraged to donate their time and talent to make a difference in the lives of others. In 2019, many of our offices around the world organized community service activities that offered employees the opportunity to work together as teams to help others. In addition, employees took time to give back to causes that are meaningful to them through volunteer activities, personal donations and intentional acts of kindness. Our collective impact was something of which we are proud - approximately 3,000 employees globally volunteered their time and gave approximately 5,000 hours back to their communities during our 2019 Month of Smiles.
|
|
•
|
Women in Leadership - Our global women@align chapters offer and encourage networking, professional development, leadership mentoring, and educational projects. The intent is to attract, develop, and retain talented women while engaging all employees. As part of our commitment, we have initiated programs and dedicated resources aimed at recruiting, monitoring and enhancing programs designed to achieve our goals. We have launched training programs that allow all employees to identify unconscious biases in an effort to increase empathy and cultural awareness. Additionally, we plan to sponsor a Global Women Leadership Summit for emerging women leaders and those early in their careers.
|
|
•
|
Month of Wellness - Launched in 2019, the Month of Wellness is a worldwide movement fostering employee health. We recognize that a strong and growing company needs healthy employees are committed to promoting wellness as part of our culture. The Month of Wellness provides employees with a variety of wellness activities and initiatives worldwide to support their overall wellbeing in areas such as nutrition, fitness, financial planning, and stress management.
|
|
•
|
Volunteer and Service Leadership - Our goal is to inspire and develop employees through serving others in the communities where they work and live. We encourage our employees to volunteer through organized company activities or on their own with volunteer time off programs for applicable employees.
|
|
•
|
Best Places to Work in IT by
Computerworld
who surveyed organizations across the U.S. to identify those that provide the best benefits and amenities for IT professionals. Among the attributes contributing to the award were our training, health insurance, retirement funding, flexible time off policies, and collaborative work environments.
|
|
•
|
Canadian Great Place to Work (GPTW) in Healthcare. To be eligible as a GPTW company, we had to be GPTW certified in the past year (certification requirements included a Culture Brief, 85% minimum survey participation, and a 7 out of 10 minimum average survey score) and work primarily in the Healthcare Sector. Companies were ranked based on employee responses to the GPTW Trust Index survey.
|
|
•
|
For the second year in a row, the
Triangle Business Journal
(TBJ) named Align's Raleigh, North Carolina office among the Top 50 Best Places to Work in the Triangle area based on employee feedback to a TBJ survey.
|
|
•
|
We opened new facilities and other sites that are closer to our customers which helps us decrease carbon emitting activities from shipping our products globally.
|
|
•
|
We have reduced the amount of plastic used in our aligners by almost 50% in just over four years. In addition, we collect and ship the majority of all scrap/waste plastics generated by our manufacturing processes to an incinerator who then uses the resulting energy to power its operations; thereby substantially reducing the plastics sent to landfills.
|
|
•
|
We have a recycling program that encourages customers and their patients to return used aligners which are then incinerated. In 2020, we expect to expand this program in the U.S. and Brazil in partnership with Terracycle, an innovative recycling company that has become a global leader in recycling hard-to-recycle materials.
|
|
•
|
In 2019, our Juarez, Mexico manufacturing sites received two awards from the State of Chihuahua in recognition of our environmental efforts; one for environmental best practices and the other for environmental compliance.
|
|
•
|
We encouraged the usage of iTero scanners to reduce the need for traditional impressions and the mining of the materials used to make those impressions.
|
|
•
|
Globally, we work to reduce the environmental impact of our processes and transportation by using energy efficient building designs and controls (e.g. solar panels, motion activated lights, LED lighting, etc.) and work to reduce emission from employee transportation by providing car charging stations to promote zero or low emission cars, incentives for carpooling, and organizing company sponsored employee transportation. We are also in the process of eliminating single use plastics in our cafeterias.
|
|
•
|
each stockholder known by us to own beneficially more than 5% of our common stock;
|
|
•
|
each of our executive officers named in the summary compensation table on page 46 of this proxy statement;
|
|
•
|
each of our directors; and
|
|
•
|
all of our directors and executive officers as a group.
|
|
Name and Address
|
|
Number of
Outstanding
Shares
Beneficially
Owned
|
|
Number of
Shares
Underlying
Options
Exercisable
and RSUs
vesting on or
before May 24,
2020
(1)
|
|
Total Shares
Beneficially
Owned
|
|
Percentage of
Outstanding
Shares
Beneficially
Owned
|
||||
|
The Vanguard Group
(2)
|
|
7,999,988
|
|
|
—
|
|
|
7,999,988
|
|
|
10.2
|
%
|
|
BlackRock, Inc.
(3)
|
|
6,468,413
|
|
|
—
|
|
|
6,468,413
|
|
|
8.2
|
%
|
|
Gordon Gund, family members and affiliated entities
(4)
|
|
5,587,081
|
|
|
—
|
|
|
5,587,081
|
|
|
7.1
|
%
|
|
Edgewood Management LLC
(5)
|
|
4,698,196
|
|
|
—
|
|
|
4,698,196
|
|
|
6.0
|
%
|
|
Joseph M. Hogan
(6)
|
|
201,236
|
|
|
—
|
|
|
201,236
|
|
|
*
|
|
|
John F. Morici
|
|
13,807
|
|
|
—
|
|
|
13,807
|
|
|
*
|
|
|
Julie Tay
|
|
28,612
|
|
|
—
|
|
|
28,612
|
|
|
*
|
|
|
Emory M. Wright
|
|
34,087
|
|
|
—
|
|
|
34,087
|
|
|
*
|
|
|
Raj Pudipeddi
|
|
2,346
|
|
|
—
|
|
|
2,346
|
|
|
*
|
|
|
Kevin J. Dallas
|
|
1,416
|
|
|
921
|
|
|
2,337
|
|
|
*
|
|
|
Joseph Lacob
|
|
183,439
|
|
|
921
|
|
|
184,360
|
|
|
*
|
|
|
C. Raymond Larkin, Jr.
|
|
31,065
|
|
|
1,228
|
|
|
32,293
|
|
|
*
|
|
|
George J. Morrow
|
|
55,557
|
|
|
921
|
|
|
56,478
|
|
|
*
|
|
|
Anne M. Myong
|
|
564
|
|
|
935
|
|
|
1,499
|
|
|
*
|
|
|
Thomas M. Prescott
|
|
136,477
|
|
|
921
|
|
|
137,398
|
|
|
*
|
|
|
Andrea L. Saia
|
|
14,066
|
|
|
921
|
|
|
14,987
|
|
|
*
|
|
|
Greg J. Santora
|
|
14,657
|
|
|
921
|
|
|
15,578
|
|
|
*
|
|
|
Susan E. Siegel
|
|
2,971
|
|
|
921
|
|
|
3,892
|
|
|
*
|
|
|
Warren S. Thaler
(7)
|
|
124,484
|
|
|
921
|
|
|
125,405
|
|
|
*
|
|
|
All current executive officers and directors as a group (23 persons)
|
|
936,140
|
|
|
9,531
|
|
|
945,671
|
|
|
1.2
|
%
|
|
*
|
Less than 1%
|
|
(1)
|
Except as otherwise set forth in the footnotes below, represents shares of common stock that can be acquired upon the exercise of stock options and vesting of restricted stock units on or before
May 24, 2020
. This column includes the full amount of restricted stock units that will vest on or before
May 24, 2020
, although each executive officer will actually receive the number of shares net of the number of shares necessary to cover any applicable withholding taxes which Align will pay on their behalf.
|
|
(2)
|
Based on a filing with the SEC on Schedule 13G/A on February 12, 2020 indicating beneficial ownership as of
December 31, 2019
. Includes shares held by direct and indirect subsidiaries. The mailing address for The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.
|
|
(3)
|
Based on a filing with the SEC on Schedule 13G/A, on February 5, 2020 indicating beneficial ownership as of
December 31, 2019
. Includes shares held by direct and indirect subsidiaries. The mailing address for BlackRock, Inc. is 55 East 52
nd
Street, New York, New York 10055.
|
|
(4)
|
Based on a filing with the SEC on Schedule 13G/A on February 7, 2020 indicating beneficial ownership as of
December 31, 2019
. Includes shares held in trust for immediate family members and shares held by immediate family members. The mailing address for Gordon Gund is P.O. Box 3599, Battlecreek, Michigan 49016-3599.
|
|
(5)
|
Based on a filing with the SEC on Schedule 13G on February 14, 2020 indicating beneficial ownership as of
December 31, 2019
. Includes shares held by advisory clients of Edgewood Management LLC, none of whom are deemed to beneficially own more than 5% of Align's common stock. The mailing address for Edgewood Management LLC is 535 Madison Avenue, 15th Floor, New York, New York 10022.
|
|
(6)
|
Includes 1,500 shares held by a member of the household.
|
|
(7)
|
Includes 43,900 shares held by Mr. Thaler and 80,084 shares held by The Thaler Family Trust for the benefit of family members as to which Mr. Thaler disclaims beneficial ownership.
|
|
•
|
you are a director or executive officer of Align and you desire to enter into a transaction with a Related Party (as defined above); or
|
|
•
|
you are an employee (other than a director or executive officer) and you desire to enter into a transaction with a Related Party that the Chief Financial Officer (in consultation with legal counsel) has deemed to be material to Align and is reportable under the rules and regulations of the Exchange Act,
|
|
THE BOARD OF DIRECTORS OF
|
|
ALIGN TECHNOLOGY, INC.
|
|
|
|
April 6, 2020
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|